<!DOCTYPE html><html lang="en" class="scroll-smooth"><head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Antiviral Antimalarial  Antineoplastic Agents - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        DocTutorial / QRP / Pharmacology
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">20</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls="">
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd"></path>
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z"></path>
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>const _0x2af812=_0x276f;(function(_0x1210ee,_0x3e4a64){const _0x9682b3=_0x276f,_0x4fabae=_0x1210ee();while(!![]){try{const _0x1cf890=-parseInt(_0x9682b3(0x3ad))/0x1*(-parseInt(_0x9682b3(0x210))/0x2)+parseInt(_0x9682b3(0x41f))/0x3*(parseInt(_0x9682b3(0x3e2))/0x4)+parseInt(_0x9682b3(0x442))/0x5*(parseInt(_0x9682b3(0x387))/0x6)+parseInt(_0x9682b3(0x39b))/0x7*(-parseInt(_0x9682b3(0x3a3))/0x8)+parseInt(_0x9682b3(0x3cd))/0x9*(parseInt(_0x9682b3(0x330))/0xa)+parseInt(_0x9682b3(0x252))/0xb*(parseInt(_0x9682b3(0x33e))/0xc)+-parseInt(_0x9682b3(0x3e5))/0xd;if(_0x1cf890===_0x3e4a64)break;else _0x4fabae['push'](_0x4fabae['shift']());}catch(_0x1441a8){_0x4fabae['push'](_0x4fabae['shift']());}}}(_0x5dfe,0x52ea6));const _0x4e6328=(function(){const _0x55dffb=_0x276f,_0x176c50={'UnShH':function(_0x3fd593){return _0x3fd593();},'JtQkf':_0x55dffb(0x1d3),'qtjTp':function(_0x3f1ce4,_0x250db4){return _0x3f1ce4!==_0x250db4;},'FtRyg':_0x55dffb(0x1da),'qpqVX':_0x55dffb(0x24c),'YeuZl':_0x55dffb(0x204),'oNinP':_0x55dffb(0x414),'ZyfmF':function(_0x50b4e4,_0x34d00a){return _0x50b4e4===_0x34d00a;}};let _0x4fa626=!![];return function(_0x400f15,_0x543ea6){const _0x126c68=_0x55dffb;if(_0x176c50[_0x126c68(0x25f)](_0x126c68(0x356),'PZNon')){if(!_0x5ee168)_0x176c50[_0x126c68(0x41b)](_0x3a9f29);_0x5d32ab[_0x126c68(0x266)][_0x126c68(0x1b0)]=_0x28c31c['referrer']||_0x176c50[_0x126c68(0x38e)];}else{const _0x517644=_0x4fa626?function(){const _0x3bf447=_0x126c68;if(_0x176c50[_0x3bf447(0x363)](_0x176c50[_0x3bf447(0x418)],_0x176c50[_0x3bf447(0x2bb)])){if(_0x543ea6){if(_0x176c50[_0x3bf447(0x1b8)]!==_0x176c50[_0x3bf447(0x1bf)]){const _0x25449a=_0x543ea6[_0x3bf447(0x3c4)](_0x400f15,arguments);return _0x543ea6=null,_0x25449a;}else{_0x400fbd[_0x3bf447(0x212)](_0x3bf447(0x2cc))[_0x3bf447(0x376)]=_0x3bf447(0x1c5);return;}}}else _0x55612d();}:function(){};return _0x4fa626=![],_0x517644;}};}()),_0x21fc30=_0x4e6328(this,function(){const _0x3baaf8=_0x276f;return _0x21fc30[_0x3baaf8(0x40e)]()[_0x3baaf8(0x3bc)](_0x3baaf8(0x436))[_0x3baaf8(0x40e)]()[_0x3baaf8(0x1d9)](_0x21fc30)[_0x3baaf8(0x3bc)](_0x3baaf8(0x436));});_0x21fc30();const _0x3e5df0=(function(){let _0x26440d=!![];return function(_0x394aaa,_0x3e945a){const _0x313daf=_0x26440d?function(){const _0x4149a2=_0x276f;if(_0x3e945a){const _0x39d9a5=_0x3e945a[_0x4149a2(0x3c4)](_0x394aaa,arguments);return _0x3e945a=null,_0x39d9a5;}}:function(){};return _0x26440d=![],_0x313daf;};}()),_0x297b48=_0x3e5df0(this,function(){const _0x2cf5a6=_0x276f,_0x542edf={'dQfWn':_0x2cf5a6(0x368),'ilxEq':function(_0x5deeef,_0x33b635){return _0x5deeef!==_0x33b635;},'btnkh':_0x2cf5a6(0x1fc),'SjjWu':function(_0x37adda,_0x501a24){return _0x37adda(_0x501a24);},'pFsNJ':function(_0x3ab25a,_0x509491){return _0x3ab25a+_0x509491;},'qbaaj':function(_0x2a8e9e,_0x2dd4bc){return _0x2a8e9e+_0x2dd4bc;},'Huzgs':_0x2cf5a6(0x228),'pSuKD':_0x2cf5a6(0x26a),'aIJsp':'warn','GTAug':_0x2cf5a6(0x1cb),'tSetD':_0x2cf5a6(0x31b),'uQDWj':_0x2cf5a6(0x26c),'ruKGw':function(_0x46bdb1,_0x296c5c){return _0x46bdb1===_0x296c5c;},'kbTYn':'tsFDU','flfcB':'bMmaB'},_0x421059=function(){const _0x4f2127=_0x2cf5a6,_0x45b405={'IjdUb':_0x542edf['dQfWn'],'AlKtV':_0x4f2127(0x3c1)};if(_0x542edf['ilxEq'](_0x4f2127(0x1fc),_0x542edf[_0x4f2127(0x2b2)]))_0x184507=_0x45b405['IjdUb'],_0xef1609=_0x45b405[_0x4f2127(0x2d4)];else{let _0x597380;try{_0x597380=_0x542edf[_0x4f2127(0x1cc)](Function,_0x542edf[_0x4f2127(0x37a)](_0x542edf[_0x4f2127(0x1ee)](_0x542edf[_0x4f2127(0x393)],_0x542edf['pSuKD']),');'))();}catch(_0x2feca3){_0x597380=window;}return _0x597380;}},_0x102588=_0x421059(),_0x1f2803=_0x102588[_0x2cf5a6(0x332)]=_0x102588[_0x2cf5a6(0x332)]||{},_0x280b2d=[_0x2cf5a6(0x218),_0x542edf[_0x2cf5a6(0x288)],_0x542edf[_0x2cf5a6(0x2b3)],_0x542edf[_0x2cf5a6(0x279)],_0x2cf5a6(0x1e0),_0x542edf['uQDWj'],'trace'];for(let _0xe8da16=0x0;_0xe8da16<_0x280b2d[_0x2cf5a6(0x3a9)];_0xe8da16++){if(_0x542edf[_0x2cf5a6(0x2c3)](_0x542edf[_0x2cf5a6(0x400)],_0x542edf[_0x2cf5a6(0x3a8)]))_0x482a9c[_0x2cf5a6(0x376)]+='<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish\x20Explanation:</p><audio\x20src=\x22'+_0x3d3359[_0x2cf5a6(0x3e8)]+_0x2cf5a6(0x3e6);else{const _0x430c98=_0x3e5df0[_0x2cf5a6(0x1d9)][_0x2cf5a6(0x227)][_0x2cf5a6(0x257)](_0x3e5df0),_0x1e416a=_0x280b2d[_0xe8da16],_0x11d1cf=_0x1f2803[_0x1e416a]||_0x430c98;_0x430c98[_0x2cf5a6(0x2d1)]=_0x3e5df0[_0x2cf5a6(0x257)](_0x3e5df0),_0x430c98[_0x2cf5a6(0x40e)]=_0x11d1cf[_0x2cf5a6(0x40e)]['bind'](_0x11d1cf),_0x1f2803[_0x1e416a]=_0x430c98;}}});_0x297b48();let questionsData=[{'id':0x1,'choices':[{'id':0x1,'text':_0x2af812(0x2e4)},{'id':0x2,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Retinal\x20detachment</span></p>'},{'id':0x3,'text':_0x2af812(0x2a1)},{'id':0x4,'text':_0x2af812(0x229)}],'text':_0x2af812(0x1c8),'unique_key':_0x2af812(0x2a7),'question_audio':null,'question_video':null,'map_id':0x13bc08,'difficulty_level':_0x2af812(0x398),'subjects_id':[0x1],'solution':_0x2af812(0x1c6),'correct_choice_id':0x1,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x2af812(0x371)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x2,'choices':[{'id':0xb,'text':_0x2af812(0x215)},{'id':0xc,'text':_0x2af812(0x348)},{'id':0xd,'text':_0x2af812(0x237)},{'id':0xe,'text':_0x2af812(0x3b2)}],'text':_0x2af812(0x243),'unique_key':_0x2af812(0x1f5),'question_audio':null,'question_video':null,'map_id':0x13bcbd,'difficulty_level':_0x2af812(0x398),'subjects_id':[0x1],'solution':'<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412238383c519-8961-4a3f-b6e1-ef062736bf94.jpg\x22>\x0d\x0a<ul>\x0d\x0a<li><em>Indinavir,\x20<strong>a\x20protease\x20inhibitor\x20</strong>causes\x20the\x20above\x20given\x20adverse\x20effects.</em></li>\x0d\x0a<li><em>AIDS\x20patients\x20being\x20treated\x20with\x20protease\x20inhibitors\x20(eg,\x20<strong>indinavir</strong>)\x20have\x20developed\x20a\x20<strong>syndrome\x20involving\x20derangement\x20of\x20lipid\x20metabolism</strong>.</em></li>\x0d\x0a<li><em>This\x20causes\x20changes\x20in\x20<strong>body\x20fat\x20distribution\x20and\x20type\x202\x20diabetes</strong>\x20has\x20also\x20been\x20reported.\x20It\x20is\x20often\x20referred\x20to\x20as\x20<strong>HIV/HAART-associated\x20lipodystrophy</strong>.</em></li>\x0d\x0a<li><em>It\x20is\x20typically\x20<strong>seen\x20after\x206-12\x20months</strong>\x20of\x20protease\x20inhibitor\x20therapy.</em></li>\x0d\x0a<li><em>Indinavir\x20is\x20also\x20notable\x20for\x20its\x20tendency\x20to\x20<strong>precipitate\x20in\x20the\x20urinary\x20tract,\x20causing\x20nephrolithiasis</strong>,\x20unless\x20the\x20patient\x20is\x20maintained\x20in\x20a\x20high\x20state\x20of\x20hydration.</em></li>\x0d\x0a</ul>\x0d\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412232dffceaf-d53c-4446-946d-374da207b47e.jpg\x22>\x0d\x0a<ul>\x0d\x0a<li><strong>Option\x20A<em>:\x20</em></strong><em>Major\x20adverse\x20effect\x20of\x20zidovudine\x20is\x20<strong>bone\x20marrow\x20suppression\x20</strong>leading\x20to\x20megaloblastic\x20anemia,\x20neutropenia\x20and\x20thrombocytopenia.</em></li>\x0d\x0a<li><strong>Option\x20C<em>:\x20</em></strong><em>Inhibition\x20of\x20CYP\x20enzymes\x20by\x20ketoconazole\x20result\x20in\x20decreased\x20formation\x20of\x20adrenal\x20and\x20gonadal\x20steroids\x20and\x20may\x20lead\x20to\x20<strong>gynaecomastia,\x20menstrual\x20irregularities\x20and\x20infertility.</strong></em></li>\x0d\x0a<li><strong>Option\x20D<em>:\x20</em></strong><em>Sulfonamides\x20can\x20displace\x20bilirubin\x20from\x20plasma\x20protein\x20binding\x20sites\x20and\x20may\x20result\x20in\x20<strong>unconjugated\x20hyperbilirubinemia\x20and\x20kernicterus\x20in\x20the\x20newborn.</strong></em></li>\x0d\x0a</ul>\x0d\x0a<p><strong><u>Key\x20Takeaway</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>AIDS\x20patients\x20being\x20treated\x20with\x20protease\x20inhibitors\x20(eg,\x20indinavir)\x20develops\x20<strong>derangement\x20of\x20lipid\x20metabolism\x20(HIV/HAART-associated\x20lipodystrophy).</strong></em></li>\x0d\x0a</ul>','correct_choice_id':0xc,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x2af812(0x371)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x3,'choices':[{'id':0x15,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Amantadine</span></p>'},{'id':0x16,'text':_0x2af812(0x1ea)},{'id':0x17,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Vidarabine</span></p>'},{'id':0x18,'text':_0x2af812(0x2a4)}],'text':_0x2af812(0x349),'unique_key':'DT1293503','question_audio':null,'question_video':null,'map_id':0x13bcbf,'difficulty_level':'intermediate','subjects_id':[0x1],'solution':_0x2af812(0x411),'correct_choice_id':0x16,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2af812(0x329),'tags':[_0x2af812(0x371)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x4,'choices':[{'id':0x1f,'text':_0x2af812(0x2a4)},{'id':0x20,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Ribavirin</span></p>'},{'id':0x21,'text':_0x2af812(0x3d6)},{'id':0x22,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Acyclovir</span></p>'}],'text':_0x2af812(0x1e5),'unique_key':_0x2af812(0x1c0),'question_audio':null,'question_video':null,'map_id':0x13bcc0,'difficulty_level':_0x2af812(0x398),'subjects_id':[0x1],'solution':'<ul>\x0d\x0a<li><strong><em><u>Ganciclovir\x20and\x20acyclovir\x20</u></em></strong><em><u>are\x20nucleoside\x20analogues\x20that\x20<strong>must\x20be\x20phosphorylated</strong>\x20first\x20by\x20virus-specific\x20enzymes</u></em><em>.</em></li>\x0d\x0a<li><em>Both\x20drugs\x20are\x20phosphorylated\x20by\x20a\x20<strong>viral\x20thymidine\x20kinase\x20in\x20herpes\x20simplex\x20virus\x20(HSV)-infected\x20cells.</strong></em></li>\x0d\x0a<li><em><u>Ganciclovir</u></em><em><u>\x20is\x20also\x20phosphorylated\x20by\x20a\x20</u></em><em><u>specific\x20viral\x20phosphotransferase\x20in\x20cytomegalovirus\x20(CMV)&minus;infected\x20cells</u></em><em>.</em></li>\x0d\x0a<li><em>This\x20explains\x20why\x20<strong>both\x20drugs\x20are\x20active\x20against\x20HSV,\x20but\x20only\x20ganciclovir\x20is\x20effective\x20against\x20CMV</strong>.</em></li>\x0d\x0a</ul>\x0d\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241223d784b563-59a8-404e-88e6-102abc9d9f3d.jpg\x22>\x0d\x0a<p><strong><em>Systemic\x20toxicity\x20of\x20ganciclovir\x20is\x20high\x20</em></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>Bone\x20marrow\x20suppression\x20</em></li>\x0d\x0a<li><em>Rash</em></li>\x0d\x0a<li><em>Fever\x20</em></li>\x0d\x0a<li><em>Vomiting\x20</em></li>\x0d\x0a<li><em>Neuropsychiatric\x20disturbances</em></li>\x0d\x0a</ul>\x0d\x0a<p>Therefore,\x20<em><u>use\x20is\x20restricted\x20to\x20prophylaxis\x20and\x20treatment\x20of\x20severe\x20CMV\x20infections\x20(pneumonia/colitis/retinitis)\x20which\x20occur\x20in\x20immunocompromised\x20(AIDS,\x20transplant\x20recipient)\x20patients</u></em>.</p>\x0d\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412239522a6fd-cf3d-474b-b739-ed1e7013eaf0.jpg\x22>\x0d\x0a<p><strong><em>Option\x20A,\x20B\x20&amp;\x20D:\x20</em></strong><em>All\x20of\x20these\x20given\x20agents\x20are\x20not\x20effective\x20against\x20CMV\x20retinitis.\x20Hence\x20not\x20preferred.\x20</em></p>\x0d\x0a<p><strong><u>Key\x20Takeaway:</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>Ganciclovir\x20is\x20a\x20nucleoside\x20analogue\x20that\x20is\x20activated\x20by\x20a<strong>\x20specific\x20viral\x20phosphotransferase</strong>\x20in\x20cytomegalovirus\x20(CMV)-infected\x20cells.</em></li>\x0d\x0a</ul>','correct_choice_id':0x21,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2af812(0x329),'tags':[_0x2af812(0x371)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x5,'choices':[{'id':0x29,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Artesunate</span></p>'},{'id':0x2a,'text':_0x2af812(0x355)},{'id':0x2b,'text':_0x2af812(0x374)},{'id':0x2c,'text':_0x2af812(0x318)}],'text':_0x2af812(0x1b5),'unique_key':_0x2af812(0x291),'question_audio':null,'question_video':null,'map_id':0x13bcc1,'difficulty_level':'intermediate','subjects_id':[0x1],'solution':'<ul>\x0d\x0a<li><em>The\x20<u>patient\x20was\x20most\x20likely\x20treated\x20with\x20<strong>chloroquine</strong>,\x20a\x20quinoline\x20derivative\x20that\x20is\x20a\x20first-line\x20agent\x20for\x20Plasmodium\x20vivax\x20and\x20P.\x20ovale\x20infections</u>.</em></li>\x0d\x0a<li><strong><em>All\x20<u>quinolines\x20can\x20prolong\x20the\x20QT\x20interval</u></em></strong><em><u>\x20on\x20an\x20electrocardiogram,\x20increasing\x20the\x20risk\x20of\x20torsades\x20de\x20pointes</u></em><em>.</em></li>\x0d\x0a<li><em>The\x20arrhythmia\x20is\x20rare,\x20but<strong>\x20its\x20occurrence\x20may\x20be\x20increased\x20in\x20patients\x20already\x20at\x20risk\x20because\x20of\x20a\x20concomitant\x20disease.</strong></em></li>\x0d\x0a</ul>\x0d\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024122392636f21-a613-43fa-8966-13da79c57d4c.jpg\x22>\x0d\x0a<ul>\x0d\x0a<li><strong>Option\x20A,\x20C\x20&amp;\x20D</strong>:\x20<em>All\x20given\x20agents\x20are\x20not\x20associated\x20with\x20development\x20of\x20arrhythmias\x20as\x20they\x20don\x27t\x20prolong\x20QT\x20interval.</em></li>\x0d\x0a</ul>\x0d\x0a<p><strong><u>Key\x20Takeaway</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>All\x20quinolines\x20can\x20<strong>prolong\x20the\x20QT\x20interval\x20</strong>on\x20an\x20electrocardiogram,\x20increasing\x20the\x20risk\x20of\x20torsades\x20de\x20pointes.</em></li>\x0d\x0a</ul>','correct_choice_id':0x2a,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2af812(0x329),'tags':[_0x2af812(0x371)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x6,'choices':[{'id':0x33,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Hypoglycemia</span></p>'},{'id':0x34,'text':_0x2af812(0x3d1)},{'id':0x35,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Arrhythmias</span></p>'},{'id':0x36,'text':_0x2af812(0x1fd)}],'text':_0x2af812(0x359),'unique_key':_0x2af812(0x3ac),'question_audio':null,'question_video':null,'map_id':0x13bcf0,'difficulty_level':_0x2af812(0x398),'subjects_id':[0x1],'solution':_0x2af812(0x33f),'correct_choice_id':0x33,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2af812(0x329),'tags':[_0x2af812(0x371)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x7,'choices':[{'id':0x3d,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Oral\x20Primaquine</span></p>'},{'id':0x3e,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Injection\x20Quinine</span></p>'},{'id':0x3f,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Intravenous\x20artesunate</span></p>'},{'id':0x40,'text':_0x2af812(0x230)}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2030\x20year\x20old\x20male\x20patient\x20had\x20a\x20travel\x20history\x20of\x20Assam.\x20After\x20coming\x20back\x20he\x20developed\x20high\x20grade\x20fever\x20with\x20chills\x20and\x20rigors\x20presented\x20to\x20the\x20emergency\x20department\x20with\x20hematuria\x20and\x20altered\x20sensorium.\x20The\x20peripheral\x20smear\x20demonstrated\x20the\x20presence\x20of\x20P.falciparum.\x20Which\x20of\x20the\x20following\x20treatments\x20should\x20be\x20immediately\x20started\x20to\x20the\x20patient?\x20</span></p>','unique_key':'DT1293562','question_audio':null,'question_video':null,'map_id':0x13bcfa,'difficulty_level':_0x2af812(0x398),'subjects_id':[0x1],'solution':_0x2af812(0x23d),'correct_choice_id':0x3f,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x2af812(0x371)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x8,'choices':[{'id':0x47,'text':_0x2af812(0x374)},{'id':0x48,'text':_0x2af812(0x3cc)},{'id':0x49,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Suramin</span></p>'},{'id':0x4a,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Mebendazole</span></p>'}],'text':_0x2af812(0x317),'unique_key':_0x2af812(0x29b),'question_audio':null,'question_video':null,'map_id':0x13bcfc,'difficulty_level':_0x2af812(0x398),'subjects_id':[0x1],'solution':'<ul>\x0d\x0a<li><em><u>Metronidazole\x20is\x20used\x20to\x20treat\x20protozoal\x20infections\x20due\x20to\x20Giardia,\x20Entamoeba,\x20and\x20Trichomonas\x20spp.</u></em></li>\x0d\x0a</ul>\x0d\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412245af72c2f-caa6-4269-b3c9-a9c6bcbf38f9.jpg\x22>\x0d\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412248180feab-455f-40cd-9e19-64585311606e.jpg\x22>\x0d\x0a<p><strong>Option\x20B</strong>:\x20Nifurtimox\x20is\x20used\x20to\x20treat\x20Chagas\x20disease\x20(due\x20to<em>\x20Trypanosoma\x20cruzii</em>).</p>\x0d\x0a<p><strong>Option\x20C</strong>:\x20Suramin\x20is\x20used\x20to\x20treat\x20African\x20trypanosomiasis.</p>\x0d\x0a<p><strong>Option\x20D</strong>:\x20Mebendazole\x20is\x20used\x20to\x20treat\x20round\x20worm\x20infections</p>\x0d\x0a<p><strong><u>Key\x20Takeaway</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>Metronidazole\x20is\x20used\x20to\x20treat\x20protozoal\x20infections\x20due\x20to\x20Giardia,\x20Entamoeba,\x20and\x20Trichomonas\x20spp.</em></li>\x0d\x0a</ul>','correct_choice_id':0x47,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2af812(0x329),'tags':[_0x2af812(0x371)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x9,'choices':[{'id':0x51,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Purine\x20phosphoribosyltransferase</span></p>'},{'id':0x52,'text':_0x2af812(0x2e7)},{'id':0x53,'text':_0x2af812(0x2cd)},{'id':0x54,'text':_0x2af812(0x2c2)}],'text':_0x2af812(0x372),'unique_key':'DT1293567','question_audio':null,'question_video':null,'map_id':0x13bcff,'difficulty_level':'intermediate','subjects_id':[0x1],'solution':_0x2af812(0x35b),'correct_choice_id':0x54,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x2af812(0x371)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xa,'choices':[{'id':0x5b,'text':_0x2af812(0x33d)},{'id':0x5c,'text':_0x2af812(0x3b9)},{'id':0x5d,'text':_0x2af812(0x1c9)},{'id':0x5e,'text':_0x2af812(0x374)}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2028\x20years\x20old\x20female\x20in\x20her\x203rd\x20trimester\x20of\x20pregnancy\x20presented\x20to\x20her\x20gynecologist\x20with\x20foul\x20smelling\x20greenish\x20vaginal\x20discharge.\x20On\x20investigation\x20there\x20were\x20clue\x20cells\x20on\x20histopathology\x20and\x20whiff\x20test\x20was\x20positive\x20in\x20vaginal\x20discharge.\x20Which\x20of\x20the\x20following\x20is\x20the\x20drug\x20of\x20choice\x20for\x20this\x20condition?\x20</span></p>','unique_key':_0x2af812(0x304),'question_audio':null,'question_video':null,'map_id':0x13bd0d,'difficulty_level':_0x2af812(0x398),'subjects_id':[0x1],'solution':'<ul>\x0d\x0a<li><em><u>The\x20diagnosis\x20is\x20<strong>Trichomonas\x20vaginitis</strong>.</u></em></li>\x0d\x0a<li><em><u>The\x20drug\x20of\x20choice\x20is\x20metronidazole\x20(2.0\x20g\x20single\x20dose\x20is\x20preferred.)\x20or\x20Tinidazole.</u></em></li>\x0d\x0a<li><em><u>Metronidazole\x20is\x20used\x20to\x20treat\x20protozoal\x20infections\x20due\x20to\x20Giardia,\x20Entamoeba,\x20and\x20Trichomonas\x20spp.</u></em></li>\x0d\x0a<li><em><u>The\x20male\x20partner\x20should\x20be\x20treated\x20concurrently\x20in\x20cases\x20of\x20recurrent\x20infections.</u></em></li>\x0d\x0a</ul>\x0d\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241224d443f2dc-1fa0-4147-9a3c-0eab3ce93b81.jpg\x22>\x0d\x0a<p><strong>Options\x20A,\x20B\x20&amp;\x20C</strong>:\x20<em>All\x20given\x20agents\x20is\x20not\x20preferred\x20choice\x20of\x20drugs\x20for\x20trichomonas\x20vaginitis\x20as\x20they\x20are\x20not\x20that\x20much\x20effective\x20as\x20metronidazole</em></p>\x0d\x0a<p><strong><u>Key\x20Takeaway</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>Metronidazole\x20is\x20used\x20to\x20treat\x20protozoal\x20infections\x20due\x20to\x20Giardia,\x20Entamoeba,\x20and\x20Trichomonas\x20spp.</em></li>\x0d\x0a</ul>','correct_choice_id':0x5e,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2af812(0x329),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xb,'choices':[{'id':0x65,'text':_0x2af812(0x245)},{'id':0x66,'text':_0x2af812(0x217)},{'id':0x67,'text':_0x2af812(0x20e)},{'id':0x68,'text':_0x2af812(0x26d)}],'text':_0x2af812(0x433),'unique_key':'DT1293588','question_audio':null,'question_video':null,'map_id':0x13bd14,'difficulty_level':_0x2af812(0x398),'subjects_id':[0x1],'solution':'<ul>\x0d\x0a<li><em>In\x20the\x20CHOP\x20acronym,\x20</em></li>\x0d\x0a<li><em><u>C\x20stands\x20for\x20<strong>cyclophosphamide</strong>;\x20</u></em></li>\x0d\x0a<li><em><u>H\x20for\x20hydroxydaunorubicin,\x20which\x20is\x20another\x20name\x20for\x20<strong>doxorubicin</strong>;</u></em></li>\x0d\x0a<li><em><u>O\x20is\x20for\x20<strong>Oncovin</strong>,</u></em></li>\x0d\x0a<li><em><u>P\x20is\x20for\x20prednisone\x20or\x20<strong>prednisolone</strong></u></em><em>.</em></li>\x0d\x0a<li><em>The\x20CHOP\x20regimen\x20has\x20been\x20considered\x20the\x20best\x20treatment\x20for\x20the\x20initial\x20therapy\x20of\x20patients\x20with\x20diffuse\x20non-Hodgkin\x20lymphoma.</em></li>\x0d\x0a<li><em><u>The\x20signs\x20and\x20symptoms\x20of\x20the\x20patient\x20suggest\x20the\x20diagnosis\x20of\x20<strong>cardiac\x20failure.</strong></u></em></li>\x0d\x0a<li><strong><em>Anthracyclines\x20(doxorubicin,\x20daunorubicin,\x20idarubicin,\x20etc.)\x20are\x20the\x20anticancer\x20drugs\x20that\x20have\x20the\x20highest\x20risk\x20of\x20cardiac\x20toxicity</em></strong><em>.</em></li>\x0d\x0a<li><em>They\x20<strong><u>can\x20cause\x20a\x20dose\x20dependent\x20dilated\x20cardiomyopathy\x20associated\x20with\x20a\x20potentially\x20fatal\x20cardiac\x20failure</u>.</strong></em></li>\x0d\x0a<li><em><u>This\x20toxicity\x20appears\x20to\x20result\x20<strong>from\x20increased\x20production\x20of\x20free\x20radicals</strong>\x20within\x20the\x20myocardium</u></em><em>.</em></li>\x0d\x0a</ul>\x0d\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412244e96c402-96e7-4695-8c38-1ada126b66ef.jpg\x22>\x0d\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024122498257a39-ed19-4184-9553-6896da502ec8.jpg\x22>\x0d\x0a<p><strong>Option\x20A</strong><em>:\x20Cyclophosphamide\x20results\x20in\x20<strong>hemorrhagic\x20cystitis,\x20</strong>cardiac\x20dysfunction,\x20pulmonary\x20toxicity\x20and\x20syndrome\x20of\x20inappropriate\x20ADH\x20secretion</em></p>\x0d\x0a<p><strong>Option\x20C</strong><em>:\x20Prednisone\x20is\x20associated\x20with\x20a\x20range\x20of\x20side\x20effects\x20including\x20opportunistic\x20infection\x20but\x20it\x20is\x20<strong>not\x20cardiotoxic.</strong></em></p>\x0d\x0a<p><strong>Option\x20D</strong><em>:\x20Vincristine\x20is\x20associated\x20with\x20development\x20of\x20<strong>peripheral\x20neuropathy</strong>\x20in\x20the\x20first\x20few\x20weeks\x20of\x20therapy\x20characterised\x20by\x20paresthesias\x20and\x20loss\x20of\x20reflexes.</em></p>\x0d\x0a<p><strong><u>Key\x20takeaway</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>Doxorubicin\x20is\x20the\x20Anthracycline\x20anticancer\x20drug\x20that\x20has\x20the\x20highest\x20risk\x20of\x20cardiac\x20toxicity,\x20it\x20can\x20cause\x20a\x20<strong>dose\x20dependent\x20dilated\x20cardiomyopathy\x20associated\x20with\x20a\x20potentially\x20fatal\x20cardiac\x20failure.</strong></em></li>\x0d\x0a</ul>','correct_choice_id':0x66,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x2af812(0x371)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xc,'choices':[{'id':0x6f,'text':_0x2af812(0x26d)},{'id':0x70,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Prednisone</span></p>'},{'id':0x71,'text':_0x2af812(0x3a4)},{'id':0x72,'text':_0x2af812(0x2ef)}],'text':_0x2af812(0x327),'unique_key':'DT1293592','question_audio':null,'question_video':null,'map_id':0x13bd18,'difficulty_level':_0x2af812(0x398),'subjects_id':[0x1],'solution':_0x2af812(0x275),'correct_choice_id':0x6f,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2af812(0x329),'tags':[_0x2af812(0x371)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xd,'choices':[{'id':0x79,'text':_0x2af812(0x340)},{'id':0x7a,'text':_0x2af812(0x286)},{'id':0x7b,'text':_0x2af812(0x1e2)},{'id':0x7c,'text':_0x2af812(0x3b0)}],'text':_0x2af812(0x34f),'unique_key':_0x2af812(0x2b0),'question_audio':null,'question_video':null,'map_id':0x13bd21,'difficulty_level':_0x2af812(0x398),'subjects_id':[0x1],'solution':_0x2af812(0x3dd),'correct_choice_id':0x7b,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x2af812(0x371)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xe,'choices':[{'id':0x83,'text':_0x2af812(0x302)},{'id':0x84,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Cytarabine</span></p>'},{'id':0x85,'text':_0x2af812(0x2b4)},{'id':0x86,'text':_0x2af812(0x3f4)}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2045\x20year\x20old\x20male\x20patient\x20with\x20a\x20history\x20of\x20blood\x20leukemia\x20with\x20mild\x20renal\x20impairment\x20came\x20to\x20an\x20oncologist\x20for\x20treatment\x20and\x20had\x20given\x20some\x20high\x20dose\x20of\x20an\x20anti-cancer\x20agent\x20following\x20which\x20he\x20developed\x20ataxia,\x20slurred\x20speech\x20with\x20megaloblastic\x20anaemia.\x20Which\x20amongst\x20the\x20following\x20anticancer\x20agents\x20is\x20associated\x20with\x20Cerebellar\x20toxicity?\x20</span></p>','unique_key':_0x2af812(0x231),'question_audio':null,'question_video':null,'map_id':0x13bd23,'difficulty_level':'intermediate','subjects_id':[0x1],'solution':_0x2af812(0x37f),'correct_choice_id':0x84,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xf,'choices':[{'id':0x8d,'text':_0x2af812(0x2b4)},{'id':0x8e,'text':_0x2af812(0x232)},{'id':0x8f,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Doxorubicin</span></p>'},{'id':0x90,'text':_0x2af812(0x3f4)}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2054\x20year\x20old\x20patient\x20with\x20a\x20history\x20of\x20having\x20some\x20form\x20of\x20cancer\x20&\x20prescribed\x20anti-cancer\x20medicines\x20for\x20the\x20same.\x20Which\x20of\x20the\x20following\x20drugs\x20can\x20cause\x20the\x20side-effects\x20given\x20in\x20the\x20picture\x20below?\x20<br><img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/1fbc74976-0f01-4335-a643-64af5e5acc5e7.jpg\x22></span></p>','unique_key':_0x2af812(0x265),'question_audio':null,'question_video':null,'map_id':0x13bd25,'difficulty_level':_0x2af812(0x398),'subjects_id':[0x1],'solution':_0x2af812(0x3ca),'correct_choice_id':0x8d,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2af812(0x329),'tags':[_0x2af812(0x371)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x10,'choices':[{'id':0x97,'text':_0x2af812(0x245)},{'id':0x98,'text':_0x2af812(0x217)},{'id':0x99,'text':_0x2af812(0x26d)},{'id':0x9a,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Bleomycin</span></p>'}],'text':_0x2af812(0x319),'unique_key':_0x2af812(0x341),'question_audio':null,'question_video':null,'map_id':0x13bd2a,'difficulty_level':_0x2af812(0x398),'subjects_id':[0x1],'solution':_0x2af812(0x3fa),'correct_choice_id':0x9a,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2af812(0x329),'tags':[_0x2af812(0x371)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x11,'choices':[{'id':0xa1,'text':_0x2af812(0x373)},{'id':0xa2,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Leuprolide</span></p>'},{'id':0xa3,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Trastuzumab</span></p>'},{'id':0xa4,'text':_0x2af812(0x2e5)}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2063-year-old\x20woman\x20complained\x20to\x20her\x20physician\x20of\x20intermittent\x20back\x20pain\x20that\x27s\x20worse\x20at\x20night.\x20History\x20revealed\x20that\x20the\x20woman\x20had\x20undergone\x20a\x20modified\x20radical\x20mastectomy\x202\x20years\x20earlier\x20for\x20infiltrating\x20ductal\x20carcinoma\x20of\x20the\x20breast\x20that\x20turned\x20out\x20to\x20be\x20HER-2\x20(human\x20epidermal\x20growth\x20factor\x20receptor\x202)\x20positive.\x20A\x20computed\x20tomography\x20scan\x20revealed\x20bone\x20metastases,\x20and\x20she\x20was\x20scheduled\x20for\x20high-dose\x20combination\x20chemotherapy.\x20Which\x20of\x20the\x20following\x20drugs\x20was\x20most\x20likely\x20included\x20in\x20her\x20treatment\x20regimen?</span></p>','unique_key':'DT1293612','question_audio':null,'question_video':null,'map_id':0x13bd2c,'difficulty_level':_0x2af812(0x398),'subjects_id':[0x1],'solution':_0x2af812(0x2e2),'correct_choice_id':0xa3,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2af812(0x329),'tags':[_0x2af812(0x371)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x12,'choices':[{'id':0xab,'text':_0x2af812(0x3a4)},{'id':0xac,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Ponatinib</span></p>'},{'id':0xad,'text':_0x2af812(0x441)},{'id':0xae,'text':_0x2af812(0x302)}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Given\x20below\x20figure\x20shows\x20the\x20mechanism\x20of\x20action\x20of\x20which\x20of\x20the\x20following\x20anti-cancer\x20drug?\x20<br><img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412243ffa055c-ca03-4fbd-9ffd-b27b2ec4c46f.jpg\x22></span></p>','unique_key':_0x2af812(0x38d),'question_audio':null,'question_video':null,'map_id':0x13bd2e,'difficulty_level':'intermediate','subjects_id':[0x1],'solution':'<ul>\x0d\x0a<li><strong><em>Tyrosine\x20kinase\x20activated\x20by\x20abl-bcr\x20fusion\x20result\x20in\x20CML.\x20This\x20enzyme\x20can\x20be\x20inhibited\x20by</em></strong>\x0d\x0a<ul>\x0d\x0a<li><strong><em>B</em></strong><strong><em>:\x20Bosutinib</em></strong></li>\x0d\x0a<li><strong><em>I</em></strong><strong><em>:\x20Imatinib</em></strong></li>\x0d\x0a<li><strong><em>N</em></strong><strong><em>:\x20Nilotinib</em></strong></li>\x0d\x0a<li><strong><em>D</em></strong><strong><em>:\x20Dasatinib</em></strong></li>\x0d\x0a<li><strong><em>Proteins</em></strong><strong><em>:\x20Ponatinib&nbsp;</em></strong><strong><em>(Mnemonic:\x20B\x20I\x20N\x20D\x20Protein)</em></strong></li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a<li><strong><em>Ponatinib</em></strong>\x0d\x0a<ul>\x0d\x0a<li><strong><em>Ponatinib\x20is\x20a\x20third-generation\x20BCR-ABL\x20kinase\x20inhibitor.</em></strong></li>\x0d\x0a<li><em><u>Imatinib\x20(first\x20generation)\x20lacks\x20efficacy\x20for\x20the\x20more\x20advanced\x20disease\x20phases</u></em><em>,\x20and\x20cells\x20with\x20mutations\x20in\x20the\x20BCR-ABL\x20tyrosine\x20kinase\x20domain\x20are\x20resistant.</em></li>\x0d\x0a<li><em><u>Second-generation\x20inhibitors\x20(nilotinib,\x20dasatinib,\x20bosutinib)\x20were\x20developed\x20to\x20address\x20these\x20weaknesses</u></em><em>,\x20although\x20they\x20do\x20not\x20inhibit\x20the\x20T315I\x20mutant\x20of\x20BCR-ABL\x20that\x20is\x20found\x20in\x2015%-20%\x20of\x20patients\x20with\x20CML.</em></li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a</ul>\x0d\x0a<p><strong>Option\x20A,\x20C\x20&amp;\x20D</strong><em>:\x20All\x20of\x20these\x20agents\x20are\x20not\x20BCR-ABL\x20kinase\x20inhibitor</em></p>\x0d\x0a<p><strong><u>Key\x20Takeaway</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>Ponatinib\x20is\x20a\x20<strong>third-generation\x20BCR-ABL\x20kinase\x20inhibitor</strong></em></li>\x0d\x0a</ul>','correct_choice_id':0xac,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2af812(0x329),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x13,'choices':[{'id':0xb5,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Dexamethasone</span></p>'},{'id':0xb6,'text':_0x2af812(0x3cf)},{'id':0xb7,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Aldesleukin</span></p>'},{'id':0xb8,'text':_0x2af812(0x3a4)}],'text':_0x2af812(0x323),'unique_key':'DT1293615','question_audio':null,'question_video':null,'map_id':0x13bd2f,'difficulty_level':_0x2af812(0x398),'subjects_id':[0x1],'solution':_0x2af812(0x1b9),'correct_choice_id':0xb6,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2af812(0x329),'tags':[_0x2af812(0x371)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x14,'choices':[{'id':0xbf,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Hypotension</span></p>'},{'id':0xc0,'text':_0x2af812(0x254)},{'id':0xc1,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Hypoglycemia</span></p>'},{'id':0xc2,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Neurotoxicity</span></p>'}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2045-year-old\x20woman\x20who\x20underwent\x20a\x20liver\x20transplant\x20started\x20an\x20immunosuppressive\x20therapy\x20that\x20included\x20tacrolimus.\x20The\x20risk\x20of\x20which\x20of\x20the\x20following\x20drug-related\x20disorders\x20were\x20most\x20likely\x20increased\x20in\x20this\x20patient?</span></p>','unique_key':_0x2af812(0x2bf),'question_audio':null,'question_video':null,'map_id':0x13bd30,'difficulty_level':_0x2af812(0x398),'subjects_id':[0x1],'solution':_0x2af812(0x395),'correct_choice_id':0xc2,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x2af812(0x371)],'explanation_video':null,'question_images':[],'explanation_images':[]}],quizName=_0x2af812(0x2f0);const quizFilename='antiviral-antimalarial-antineoplastic-agents-139bd3fa.html';let hierarchy=[_0x2af812(0x1af),_0x2af812(0x3f5),'Pharmacology'];if(window[_0x2af812(0x266)]['pathname']['endsWith']('custom_quiz.html')){const customData=JSON[_0x2af812(0x206)](localStorage[_0x2af812(0x200)]('customQuizData'));if(customData){const ptNrVJ=_0x2af812(0x216)['split']('|');let pTuozc=0x0;while(!![]){switch(ptNrVJ[pTuozc++]){case'0':document[_0x2af812(0x212)](_0x2af812(0x285))[_0x2af812(0x41e)]=hierarchy[_0x2af812(0x35d)]('\x20>\x20');continue;case'1':hierarchy=customData[_0x2af812(0x448)];continue;case'2':document[_0x2af812(0x212)]('totalQuestions')[_0x2af812(0x41e)]=questionsData[_0x2af812(0x3a9)];continue;case'3':quizName=customData[_0x2af812(0x1df)];continue;case'4':questionsData=customData[_0x2af812(0x2ae)];continue;case'5':document['title']=quizName+_0x2af812(0x346);continue;}break;}}}let currentQuestionIndex=0x0,selectedOption=null,currentMode='study',timer=null,timeRemaining=0x0,questionStartTime=Date['now'](),quizStartTime=Date[_0x2af812(0x3ef)](),isQuizCompleted=![],questionStates=new Array(questionsData[_0x2af812(0x3a9)])[_0x2af812(0x273)](null)[_0x2af812(0x21a)](()=>({'status':_0x2af812(0x223),'bookmarked':![],'markedForReview':![],'selectedAnswer':null,'timeSpent':0x0})),stats={'correctAnswers':0x0,'incorrectAnswers':0x0,'totalAttempted':0x0,'totalTime':0x0,'notAttempted':questionsData[_0x2af812(0x3a9)]};function saveProgress(){const _0x508be8=_0x2af812,_0x2c8f9a={'qlHmF':_0x508be8(0x2ad),'JCiIr':_0x508be8(0x389)};if(isQuizCompleted)return;const _0x255845=JSON[_0x508be8(0x206)](localStorage[_0x508be8(0x200)](_0x2c8f9a['qlHmF']))||{};_0x255845[quizFilename]={'questionStates':questionStates,'stats':stats,'currentQuestionIndex':currentQuestionIndex,'currentMode':currentMode,'status':_0x2c8f9a[_0x508be8(0x352)],'lastSeen':new Date()[_0x508be8(0x248)]()},localStorage[_0x508be8(0x2f7)](_0x2c8f9a[_0x508be8(0x3ea)],JSON['stringify'](_0x255845));}function loadProgress(){const _0x1fea61=_0x2af812,_0x5548bc={'VOIaI':'0|4|3|5|2|1','fAeYl':_0x1fea61(0x241)},_0x1f9c7b=JSON[_0x1fea61(0x206)](localStorage[_0x1fea61(0x200)](_0x1fea61(0x2ad)))||{},_0x1711ca=_0x1f9c7b[quizFilename];if(_0x1711ca){const _0x2dd226=_0x5548bc[_0x1fea61(0x362)][_0x1fea61(0x1f8)]('|');let _0xf08230=0x0;while(!![]){switch(_0x2dd226[_0xf08230++]){case'0':questionStates=_0x1711ca[_0x1fea61(0x1fb)];continue;case'1':return!![];case'2':console[_0x1fea61(0x218)](_0x5548bc['fAeYl']);continue;case'3':currentQuestionIndex=_0x1711ca[_0x1fea61(0x31e)];continue;case'4':stats=_0x1711ca[_0x1fea61(0x364)];continue;case'5':currentMode=_0x1711ca['currentMode'];continue;}break;}}return![];}function clearProgress(){const _0x5c59da=_0x2af812,_0x28b32f={'kVnvP':_0x5c59da(0x2ad)},_0xfd1ffd=JSON[_0x5c59da(0x206)](localStorage[_0x5c59da(0x200)](_0x28b32f['kVnvP']))||{};_0xfd1ffd[quizFilename]&&(delete _0xfd1ffd[quizFilename],localStorage[_0x5c59da(0x2f7)](_0x28b32f[_0x5c59da(0x2cf)],JSON[_0x5c59da(0x33c)](_0xfd1ffd)),console['log'](_0x5c59da(0x1c7)));}function markQuizAsCompleted(){const _0x34152d=_0x2af812,_0x46c590={'HUJDb':_0x34152d(0x2ad)},_0x403120=JSON[_0x34152d(0x206)](localStorage[_0x34152d(0x200)](_0x46c590[_0x34152d(0x2f8)]))||{},_0x16e84b=questionsData[_0x34152d(0x3a9)],_0x18298a=stats[_0x34152d(0x208)]||0x0;_0x403120[quizFilename]={'score':_0x18298a,'total':_0x16e84b,'status':'completed','completedOn':new Date()[_0x34152d(0x248)]()},localStorage['setItem'](_0x46c590[_0x34152d(0x2f8)],JSON[_0x34152d(0x33c)](_0x403120));}const urlParams=new URLSearchParams(window[_0x2af812(0x266)][_0x2af812(0x3bc)]),startAt=parseInt(urlParams[_0x2af812(0x290)](_0x2af812(0x38f))),resume=urlParams[_0x2af812(0x290)](_0x2af812(0x1e3))===_0x2af812(0x2b1);function _0x5dfe(){const _0x243d85=['txDnZ','aIJsp','.option-button','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish\x20Explanation:</p><audio\x20src=\x22','gradient-yellow\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','JJxAF','rFUJA','WpFSB','HKDsQ','get','DT1293505','wwDyM','You\x20have\x20completed\x20all\x20questions.\x20Would\x20you\x20like\x20to\x20review\x20from\x20the\x20beginning?','FhsYI','ZdhKS','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-yellow-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','nav-btn-bookmarked','questionIndex','KuUsR','cWclI','DT1293564','nMUgS','DkkTq','test','OCtHb','Option\x20','<p><span\x20style=\x22font-size:12.0pt;\x22>Cataract</span></p>','sdicE','AZisR','<p><span\x20style=\x22font-size:12.0pt;\x22>Foscarnet</span></p>','timerContainer','LtBAe','DT1293320','review-question\x20','5|0|2|1|3|4','explanation_images','KQNxH','correct','userHistory','questions','replace','DT1293601','true','btnkh','GTAug','<p><span\x20style=\x22font-size:12.0pt;\x22>Bleomycin</span></p>','questionReviewSection','XPbkh','bbaWP','hjwhs','wasvE','TGHPb','qpqVX','accuracy','target','iVfnz','DT1293616','nav-btn-correct','createElement','<p><span\x20style=\x22font-size:12.0pt;\x22>Dihydrofolate\x20reductase</span></p>','ruKGw','LJkmU','JUYJs','VnUNz','PMfPe','\x20>\x20','KlkLt','ExzKh','disabled','questionText','<p><span\x20style=\x22font-size:12.0pt;\x22>Ferredoxin\x20oxidoreductase</span></p>','XWYZY','kVnvP','bFwZe','__proto__','ArrowLeft','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><audio\x20src=\x22','AlKtV','bVUzk','closest','quizFile','FsQKP','push','statsBar','LnHuO','No\x20question\x20text\x20available','RdzTU','Ssqof','timed_exam','SUItb','UgKSb','<ul>\x0d\x0a<li><em><u>Trastuzumab\x20is\x20a\x20monoclonal\x20antibody\x20against\x20a\x20surface\x20protein\x20called\x20human\x20epidermal\x20growth\x20factor\x20receptor\x202\x20(HER-2),\x20which\x20may\x20be\x20overexpressed\x20in\x20primary\x20breast\x20carcinoma</u></em><em>.</em></li>\x0d\x0a<li><em>The\x20drug\x20binds\x20with\x20high\x20affinity\x20to\x20this\x20receptor,\x20thus\x20preventing\x20the\x20binding\x20of\x20HER\x20to\x20the\x20same\x20receptor.\x20In\x20this\x20way,\x20tumor\x20growth\x20is\x20inhibited.</em></li>\x0d\x0a<li><strong><em>Trastuzumab\x20is\x20used\x20in\x20HER-2\x20positive,\x20metastasized\x20breast\x20cancer,\x20alone\x20or\x20in\x20combination\x20with\x20paclitaxel</em></strong><em>.</em></li>\x0d\x0a</ul>\x0d\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412241636e560-67fc-4c0b-8bc3-f6ceaffc7dee.jpg\x22>\x0d\x0a<p><strong>Option\x20A,\x20B\x20&amp;\x20D</strong><em>:\x20All\x20of\x20these\x20agents\x20are\x20not\x20first\x20choice\x20in\x20metastatic\x20breast\x20cancer.</em></p>\x0d\x0a<p><strong><u>Key\x20Takeaway</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>Trastuzumab\x20is\x20used\x20in\x20<strong>HER-2\x20positive,\x20metastasized\x20breast\x20cancer,\x20alone\x20or\x20in\x20combination\x20with\x20paclitaxel.</strong></em></li>\x0d\x0a</ul>','ywpCP','<p><span\x20style=\x22font-size:12.0pt;\x22>Anemia\x20and\x20neutropenia</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Flutamide</span></p>','laGqj','<p><span\x20style=\x22font-size:12.0pt;\x22>Ornithine\x20decarboxylase</span></p>','submitSection','ruaHW','pop','completed','pathname','AkSeT','yHpeH','<p><span\x20style=\x22font-size:12.0pt;\x22>Mercaptopurine</span></p>','Antiviral\x20Antimalarial\x20\x20Antineoplastic\x20Agents','ECash','xWBvx','forEach','IvPsw','incorrectCount','shJkq','setItem','HUJDb','text','FxXnO','green','OtzfX','KKuii','MtxzD','TWCmM','GwSXW','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-purple-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','<p><span\x20style=\x22font-size:12.0pt;\x22>Cisplatin</span></p>','KfoAi','DT1293581','zjZOu','bgVJK','currentQuestion','markReviewBtn','HLvDT','solution','none','QKzqg','SICeC','miaZd','HvgcS','lZIAc','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22space-y-2\x20mb-4\x22>','nav-btn-not-attempted\x20hover:bg-white\x20hover:bg-opacity-20','toggle','XdOmS','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><img\x20src=\x22','Bookmarked','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2014-year-old\x20boy\x20returns\x20from\x20a\x20hiking\x20trip\x20with\x20foul-smelling\x20watery\x20diarrhea.\x20On\x20further\x20questioning,\x20he\x20admits\x20to\x20drinking\x20water\x20from\x20a\x20mountain\x20source\x20without\x20first\x20boiling\x20it.\x20Stool\x20is\x20sent\x20for\x20ova\x20and\x20parasites,\x20confirming\x20the\x20diagnosis\x20of\x20Giardia\x20lamblia\x20infection.\x20Which\x20of\x20the\x20following\x20drugs\x20is\x20appropriate\x20treatment?</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Iodoquinol</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2060-year-old\x20man\x20was\x20admitted\x20to\x20the\x20hospital\x20with\x20fever,\x20dyspnea\x20and\x20nonproductive\x20cough.\x20Two\x20weeks\x20earlier,\x20the\x20patient\x20had\x20completed\x20five\x20courses\x20of\x20chemotherapy\x20with\x20cyclophosphamide,\x20doxorubicin,\x20vincristine,\x20prednisone\x20and\x20bleomycin\x20for\x20large-cell\x20lymphoma.\x20Chest\x20x-ray\x20showed\x20diffuse\x20bilateral\x20infiltrates\x20and\x20a\x20lung\x20biopsy\x20revealed\x20inflammation\x20and\x20fibrosis\x20with\x20no\x20evidence\x20of\x20lymphoma.\x20Which\x20of\x20the\x20drugs\x20administered\x20to\x20the\x20patient\x20most\x20likely\x20caused\x20his\x20pulmonary\x20disorder?</span></p>','XXmcx','error','XjzUu','application/vnd.apple.mpegurl','currentQuestionIndex','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20transition-all\x20duration-200','jXxCO','nzLtg','No\x20solution\x20provided','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2042-year-old\x20woman\x20who\x20had\x20been\x20undergoing\x20hemodialysis\x20for\x203\x20years\x20was\x20admitted\x20to\x20the\x20hospital\x20for\x20a\x20kidney\x20transplant.\x20Before\x20and\x20after\x20surgery,\x20she\x20received\x20cyclosporine,\x20azathioprine\x20and\x20prednisone.\x20Four\x20days\x20after\x20surgery,\x20she\x20developed\x20acute\x20allograft\x20rejection.\x20High-dose\x20prednisone\x20failed\x20to\x20resolve\x20the\x20rejection.\x20Which\x20of\x20the\x20following\x20drugs\x20could\x20be\x20used\x20to\x20treat\x20this\x20case\x20of\x20steroid-resistant\x20rejection?</span></p>','TMLlQ','iVSix','wsksi','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2026-year-old\x20man\x20complained\x20of\x20numbness\x20in\x20his\x20fingers\x20and\x20the\x20soles\x20of\x20his\x20feet.\x20Three\x20weeks\x20previously,\x20he\x20had\x20started\x20chemotherapy\x20for\x20acute\x20lymphoblastic\x20leukemia.\x20Physical\x20examination\x20showed\x20loss\x20of\x20ankle\x20jerk\x20and\x20depression\x20of\x20deep\x20tendon\x20reflexes.\x20Which\x20of\x20the\x20following\x20drugs\x20most\x20likely\x20caused\x20the\x20patient\x27s\x20signs\x20and\x20symptoms?</span></p>','psSYa','bottom','SXVXL','qUWzd','jpPdI','QnbMA','gyCFL','ODrhc','1509590ehGpww','gmCNs','console','DQAos','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<button\x20type=\x22button\x22\x20class=\x22option-button\x20','rHIfe','fvdWn','pTgOh','NpFEG','solutionVideo','foqdA','VHpuc','stringify','<p><span\x20style=\x22font-size:12.0pt;\x22>Doxycycline</span></p>','21372WrUVQa','<p><strong><em><u>Cinchonism</u></em></strong><em><u>\x20:</u></em></p>\x0d\x0a<ul>\x0d\x0a<li><em>A\x20large\x20single\x20dose\x20or\x20<u>higher\x20therapeutic\x20doses\x20taken\x20for\x20a\x20few\x20days\x20produce\x20a\x20syndrome\x20called\x20\x27cinchonism\x27</u>.</em></li>\x0d\x0a<li><em>It\x20consists\x20of</em>\x0d\x0a<ul>\x0d\x0a<li><strong><em>Ringing\x20in\x20ears</em></strong></li>\x0d\x0a<li><strong><em>Nausea,\x20vomiting\x20(due\x20to\x20both\x20gastric\x20irritation\x20and\x20CTZ\x20stimulation)</em></strong></li>\x0d\x0a<li><strong><em>Headache</em></strong></li>\x0d\x0a<li><strong><em>Mental\x20confusion</em></strong></li>\x0d\x0a<li><strong><em>Vertigo\x20</em></strong></li>\x0d\x0a<li><strong><em>Difficulty\x20in\x20hearing\x20and\x20visual\x20defects\x20(due\x20to\x20direct\x20neurotoxicity\x20as\x20well\x20as\x20constriction\x20of\x20retinal\x20and\x20auditory\x20vessels)</em></strong></li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a<li><em>Diarrhoea,\x20flushing\x20and\x20marked\x20perspiration</em></li>\x0d\x0a<li><em>Delirium,\x20fever,\x20tachypnoea\x20followed\x20by\x20respiratory\x20depression,\x20pulmonary\x20edema,\x20hypoglycaemia,\x20marked\x20weakness\x20and\x20prostration\x20can\x20occur.</em></li>\x0d\x0a<li><strong><em>Hypotension,\x20cardiac\x20arrhythmias\x20(Q-T\x20prolongation\x20)\x20develop\x20only\x20on\x20rapid\x20i.v.\x20injection</em></strong></li>\x0d\x0a<li><em><u>Quinine\x20occasionally\x20causes\x20haemolysis,\x20especially\x20in\x20pregnant\x20women\x20and\x20in\x20patients\x20of\x20falciparum\x20malaria,\x20resulting\x20in\x20haemoglobinuria\x20(black\x20water\x20fever)\x20and\x20kidney\x20damage</u></em><em>.</em></li>\x0d\x0a<li><em><u>During\x20pregnancy\x20it\x20should\x20be\x20used\x20only\x20for\x20serious\x20falciparum\x20malaria,\x20with\x20special\x20care\x20to\x20prevent\x20hypoglycemia</u></em><em>.</em></li>\x0d\x0a</ul>\x0d\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024122419d97e86-9554-4eac-bc80-bee6a053a451.jpg\x22>\x0d\x0a<p><strong><u>Key\x20Takeaway</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>Quinine\x20can\x20cause\x20hypoglycemia\x20manifested\x20by\x20palpitations,\x20sweating\x20and\x20tachycardia.\x20<strong><u>To\x20prevent\x20hypoglycemia,\x20i.v.\x20infusion\x20of\x20quinine\x20should\x20always\x20be\x20given\x20in\x205%\x20dextrose\x20solution\x20(instead\x20of\x20normal\x20saline).</u></strong></em></li>\x0d\x0a</ul>','<p><span\x20style=\x22font-size:12.0pt;\x22>Cisplatin\x20</span></p>','DT1293610','Ovwyg','\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-letter\x22>','explanation_video','NnNXy','\x20-\x20Brain\x20And\x20Scalpel','RGwDZ','<p><span\x20style=\x22font-size:12.0pt;\x22>Indinavir</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2023-year-old\x20immunocompetent\x20woman\x20sees\x20her\x20family\x20physician\x20with\x20painful\x20\x22bumps\x22\x20on\x20her\x20labia\x20and\x20vulva.\x20On\x20examination,\x20there\x20are\x20vesicles\x20in\x20the\x20described\x20region.\x20You\x20suspect\x20herpes\x20simplex\x20infection\x20on\x20clinical\x20grounds\x20and\x20recommend\x20which\x20of\x20the\x20following?</span></p>','open','blCzw','question_audio','QwhVs','ouyIb','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2056\x20year\x20old\x20patient\x20developed\x20the\x20following\x20lesions\x20after\x2010\x20days\x20of\x20treatment.\x20Patient\x20also\x20complain\x20of\x20similar\x20lesions\x20over\x20soles\x20and\x20they\x20are\x20sensitive\x20to\x20touch.\x20The\x20most\x20likely\x20agent\x20to\x20cause\x20that\x20adverse\x20effect\x20is?<br><img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/1fb8c9f53-d422-4a5d-a794-37a9cf4dd5af6.jpg\x22></span></p>','timeSpent','PyxVi','JCiIr','preventDefault','HBVZa','<p><span\x20style=\x22font-size:12.0pt;\x22>Chloroquine</span></p>','aCdOD','bookmarkText','wWvOU','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2027\x20year\x20old\x20pregnant\x20female\x20living\x20in\x20an\x20endemic\x20area\x20presented\x20to\x20the\x20medicine\x20department\x20with\x20complaints\x20of\x20high\x20grade\x20fever,\x20headache,\x20abdominal\x20pain,\x20hematuria\x20and\x20extreme\x20fatigue.\x20She\x20was\x20diagnosed\x20of\x20having\x20severe\x20falciparum\x20malaria\x20and\x20she\x20was\x20being\x20administered\x20i.v.\x20quinine\x20following\x20which\x20she\x20developed\x20restlessness\x20and\x20sweating.\x20Which\x20of\x20the\x20following\x20is\x20the\x20most\x20likely\x20side\x20effect\x20produced\x20by\x20quinine?\x20</span></p>','Ttfuv','<ul>\x0d\x0a<li><em>The\x20<strong>patient\x20most\x20likely\x20received\x20a\x20sulfadiazine&minus;pyrimethamine\x20combination\x20that\x20represents\x20the\x20standard\x20therapy\x20for\x20toxoplasmosis.</strong></em></li>\x0d\x0a<li><em><u>Pyrimethamine\x20selectively\x20inhibits\x20protozoal\x20dihydrofolate\x20reductase,\x20a\x20key\x20enzyme\x20for\x20folate\x20biosynthesis\x20in\x20the\x20parasite</u></em><em>.</em></li>\x0d\x0a<li><em>This\x20in\x20turn\x20leads\x20to\x20failure\x20in\x20DNA\x20synthesis\x20and\x20nuclear\x20division.</em></li>\x0d\x0a</ul>\x0d\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241224e3dd8baf-3799-477a-ad48-11260a62e614.jpg\x22>\x0d\x0a<p><strong><u>Key\x20Takeaway</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>Pyrimethamine\x20selectively\x20inhibits\x20protozoal\x20dihydrofolate\x20reductase,\x20a\x20key\x20enzyme\x20for\x20folate\x20biosynthesis\x20in\x20the\x20parasite.</em></li>\x0d\x0a</ul>','RKNbf','join','RogqO','nav-btn-current','GbBLa','DaGxR','VOIaI','qtjTp','stats','yoSXl','FtdgA','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><video\x20src=\x22','incorrect','WwOhY','ePSUh','izdlW','navBtn_','selected','MTWml','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22bg-green-900\x20bg-opacity-20\x20p-4\x20rounded-lg\x20border\x20border-green-700\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h5\x20class=\x22text-green-400\x20font-bold\x20mb-2\x22>Explanation:</h5>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20text-opacity-90\x22>','mipvp','Factual','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2030-year-old\x20man\x20with\x20AIDS\x20was\x20admitted\x20to\x20the\x20hospital\x20with\x20the\x20preliminary\x20diagnosis\x20of\x20pneumonia.\x20Further\x20tests\x20led\x20to\x20the\x20diagnosis\x20of\x20toxoplasmosis,\x20and\x20an\x20appropriate\x20combination\x20therapy\x20was\x20started.\x20Inhibition\x20of\x20which\x20of\x20the\x20following\x20protozoal\x20enzymes\x20most\x20likely\x20mediated\x20the\x20therapeutic\x20effect\x20of\x20the\x20therapy\x20in\x20this\x20patient?</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Clomiphene</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Metronidazole</span></p>','click','innerHTML','sBcSj','explanation_audio_eng','jkLuK','pFsNJ','TXdzb','jQbPg','vyiDb','GVctV','<p><strong><em><u>Adverse\x20Effects\x20of\x20Cytarabine</u></em></strong></p>\x0d\x0a<ul>\x0d\x0a<li><strong><em>Cytarabine\x20is\x20myelosuppressive\x20and\x20can\x20produce\x20acute,\x20severe\x20leukopenia,\x20thrombocytopenia,\x20and\x20anemia\x20with\x20striking\x20megaloblastic\x20changes.</em></strong></li>\x0d\x0a<li><em><u>Other\x20toxic\x20manifestations\x20include\x20</u></em>\x0d\x0a<ul>\x0d\x0a<li><em>GI\x20disturbances</em></li>\x0d\x0a<li><em>Stomatitis</em></li>\x0d\x0a<li><em>Conjunctivitis</em></li>\x0d\x0a<li><em>Reversible\x20hepatic\x20enzyme\x20elevations\x20</em></li>\x0d\x0a<li><em>Noncardiogenic\x20pulmonary\x20edema</em></li>\x0d\x0a<li><em>Dermatitis</em></li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a<li><em>The\x20onset\x20of\x20dyspnea,\x20fever,\x20and\x20pulmonary\x20infiltrates\x20on\x20chest\x20computed\x20tomographic\x20scans\x20may\x20follow\x201-2\x20weeks\x20after\x20high-dose.</em></li>\x0d\x0a<li><strong><em>Cerebellar\x20toxicity,\x20manifesting\x20as\x20ataxia\x20and\x20slurred\x20speech</em></strong></li>\x0d\x0a<li><strong><em><u>Cerebral\x20toxicity\x20(seizures,\x20dementia,\x20and\x20coma)\x20may\x20follow\x20intrathecal\x20administration\x20or\x20high-dose\x20systemic\x20administration,\x20especially\x20in\x20patients\x20older\x20than\x2040\x20years\x20or\x20patients\x20with\x20poor\x20renal\x20function</u></em></strong><strong><em>.</em></strong></li>\x0d\x0a</ul>\x0d\x0a<p><strong>Option\x20A:\x20</strong><em>Cisplatin\x20is\x20associated\x20with\x20<strong>nausea\x20and\x20vomiting\x20</strong>(maximum\x20among\x20all\x20anti-cancer\x20drugs).\x20It\x20is\x20mild\x20bone\x20marrow\x20suppressants\x20and\x20are\x20nephrotoxic,\x20ototoxic\x20as\x20well\x20as\x20neurotoxic.</em></p>\x0d\x0a<p><strong>Option\x20C:\x20</strong><em>Bleomycin\x20results\x20in\x20<strong>cutaneous\x20toxicity\x20</strong>(hyperpigmentation,\x20hyperkeratosis,\x20erythema\x20and\x20ulcers),\x20pneumonitis,\x20<strong>pulmonary\x20fibrosis</strong>,\x20hypersensitivity\x20and\x20mucocutaneous\x20reactions\x20(particularly\x20<strong>flagellated\x20pigmentation\x20of\x20skin).</strong></em></p>\x0d\x0a<p><strong>Option\x20D:\x20</strong><em>Prominent\x20adverse\x20effects\x20of\x20Actinomycin\x20D\x20are\x20vomiting,\x20stomatitis,\x20diarrhoea,\x20erythema\x20and\x20<strong>desquamation\x20of\x20skin,\x20alopecia\x20and\x20bone\x20marrow\x20depression.</strong></em></p>\x0d\x0a<p><strong><u>Key\x20takeaway</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><strong><em>Cerebellar\x20toxicity\x20</em></strong><em>may\x20follow\x20intrathecal\x20administration\x20or\x20high-dose\x20systemic\x20administration\x20of\x20Cytarabine,\x20manifesting\x20as\x20<strong>ataxia\x20and\x20slurred\x20speech.</strong></em></li>\x0d\x0a</ul>','egcce','\x22><span\x20class=\x22font-bold\x20mr-3\x22>','pWuMp','width','DsPzu','tLded','\x22\x20controls\x20class=\x22w-full\x20rounded-lg\x22></video></div>','258NJHBfI','includes','incomplete','oNtRW','Correct','gJewz','DT1293614','JtQkf','startAt','EmcSw','rVwml','kBdpE','Huzgs','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-text\x22>','<ul>\x0d\x0a<li><em><u>Neurotoxicity\x20and\x20nephrotoxicity\x20are\x20the\x20two\x20major\x20adverse\x20effects\x20of\x20tacrolimus,\x20occurring\x20in\x20more\x20than\x2050%\x20of\x20patients\x20receiving\x20this\x20drug</u></em><em>.</em></li>\x0d\x0a<li><em><u>Neurotoxicity\x20includes\x20headache,\x20insomnia,\x20tremor,\x20paresthesias,\x20and\x20seizures</u></em><em>.</em></li>\x0d\x0a<li><strong><em>Side\x20effects:\x204\x20H</em></strong>\x0d\x0a<ul>\x0d\x0a<li><em>Hypertension</em></li>\x0d\x0a<li><em>Hirsutism</em></li>\x0d\x0a<li><em>Gum\x20hyperplasia\x20</em></li>\x0d\x0a<li><em>Hyperuricemia</em></li>\x0d\x0a<li><em><u>Tacrolimus\x20is\x20likely\x20to\x20precipitate\x20diabetes,\x20cause\x20neurotoxicity,\x20alopecia\x20and\x20diarrhoea</u></em><em>.</em></li>\x0d\x0a<li><strong><em>Dose\x20limiting\x20toxicity\x20is\x20renal.</em></strong></li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a</ul>\x0d\x0a<p>Option\x20A\x20:\x20Tacrolimus\x20can\x20cause\x20Hypertension,\x20Not\x20Hypotension.</p>\x0d\x0a<p>Option\x20B\x20:\x20Tacrolimus\x20Causes\x20Hyperkalemia,\x20not\x20Hypokalemia.</p>\x0d\x0a<p>Option\x20C\x20:\x20Tacrolimus\x20Can\x20cause\x20Hyperglycemia\x20and\x20Precipitate\x20Diabetes\x20Not\x20Hypoglycemia.</p>\x0d\x0a<p><strong><u>Key\x20Takeaway</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><strong><em>Neurotoxicity\x20and\x20nephrotoxicity</em></strong><em>\x20are\x20the\x20two\x20major\x20adverse\x20effects\x20of\x20tacrolimus,\x20occurring\x20in\x20more\x20than\x2050%\x20of\x20patients\x20receiving\x20this\x20drug.</em></li>\x0d\x0a</ul>','key','quXjt','intermediate','<div\x20class=\x22mt-4\x22><img\x20src=\x22','bookmarkBtn','126679dwHXqy','wMQAe','EGYdk','eTxey','Lrwtd','PrpnF','testModeReviewLegend','nav-btn-incorrect','8bYqJBN','<p><span\x20style=\x22font-size:12.0pt;\x22>Methotrexate</span></p>','pGuDp','questionNav','OmfyN','flfcB','length','LcbaL','ACAds','DT1293552','48591ZnyYiM','CeItr','add','<p><span\x20style=\x22font-size:12.0pt;\x22>Mitomycin-C\x20</span></p>','NMmdy','<p><span\x20style=\x22font-size:12.0pt;\x22>Sulfamethoxazole</span></p>','BPxgR','accuracyScore','gWuuz','bTMTd','remove','GXYqG','<p><span\x20style=\x22font-size:12.0pt;\x22>Fluconazole</span></p>','UhypX','azmBl','search','ueEFg','KEvXq','bSEyY','\x22\x20data-option-index=\x22','Incorrect','aAIDL','POjBJ','apply','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','JedJN','YnsqR','FYngk','AQMvg','<p><strong><em><u>Bleomycin\x20:</u></em></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>It\x20is\x20a\x20glycopeptide\x20drug\x20that\x20acts\x20in\x20the\x20<strong>G2\x20phase</strong>\x20by\x20causing\x20DNA\x20strand\x20breakage\x20and\x20free\x20radical\x20formation.</em></li>\x0d\x0a<li><em>It\x20can\x20result\x20in</em>\x0d\x0a<ul>\x0d\x0a<li><strong><em><u>Cutaneous\x20toxicity</u></em></strong><em><u>\x20(hyperpigmentation,\x20hyperkeratosis,\x20erythema\x20and\x20ulcers),\x20pneumonitis,\x20</u></em></li>\x0d\x0a<li><strong><em><u>Pulmonary\x20fibrosis,</u></em></strong></li>\x0d\x0a<li><em><u>Hypersensitivity\x20and\x20</u></em></li>\x0d\x0a<li><strong><em><u>Mucocutaneous\x20reactions\x20(particularly\x20flagellated\x20pigmentation\x20of\x20skin).</u></em></strong></li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a<li><strong><em><u>It\x20causes\x20necrosis\x20of\x20type\x20I\x20pneumocytes\x20</u></em></strong><em><u>that\x20results\x20in\x20compensatory\x20hyperplasia\x20of\x20type\x20II\x20pneumocytes.</u></em></li>\x0d\x0a<li><em><u>Bleomycin\x20is\x20metabolized\x20by\x20<strong>bleomycin\x20hydrolase</strong>,\x20whose\x20concentration\x20is\x20less\x20in\x20skin\x20and\x20lungs\x20(thus\x20major\x20organs\x20involved\x20in\x20toxicity).</u></em></li>\x0d\x0a</ul>\x0d\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/13f8c2cb2-06ef-4b34-be62-4692caad020d8.jpg\x22>\x0d\x0a<p><strong>Option\x20B</strong><em>:\x20Mitomycin\x20C\x20is\x20associated\x20with\x20bone\x20marrow\x20and\x20g.i.t.\x20are\x20the\x20primary\x20targets\x20of\x20toxicity.\x20<strong>Myelosuppression\x20is\x20typically\x20delayed.\x20A\x20haemolytic-uremic\x20syndrome\x20is\x20reported.</strong></em></p>\x0d\x0a<p><strong>Option\x20C</strong>:\x20<em>Doxorubicin\x20is\x20the\x20Anthracycline\x20anticancer\x20drug\x20that\x20has\x20the\x20highest\x20risk\x20of\x20cardiac\x20toxicity,\x20it\x20can\x20cause\x20<strong>a\x20dose\x20dependent\x20dilated\x20cardiomyopathy\x20associated\x20with\x20a\x20potentially\x20fatal\x20cardiac\x20failure.</strong></em></p>\x0d\x0a<p><strong>Option\x20D:\x20</strong><em>Prominent\x20adverse\x20effects\x20of\x20Actinomycin\x20D\x20are\x20vomiting,\x20stomatitis,\x20diarrhoea,\x20erythema\x20and\x20<strong>desquamation\x20of\x20skin,\x20alopecia\x20and\x20bone\x20marrow\x20depression.</strong></em></p>\x0d\x0a<p><strong><u>Key\x20takeaway</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>Bleomycin\x20results\x20in\x20<strong>cutaneous\x20toxicity</strong>\x20(hyperpigmentation,\x20hyperkeratosis,\x20erythema\x20and\x20ulcers),\x20pneumonitis,\x20pulmonary\x20fibrosis,\x20hypersensitivity\x20and\x20<strong><u>mucocutaneous\x20reactions\x20(particularly\x20flagellated\x20pigmentation\x20of\x20skin).</u></strong></em></li>\x0d\x0a</ul>','fdjSk','<p><span\x20style=\x22font-size:12.0pt;\x22>Nifurtimox</span></p>','36evEtsn','findIndex','<p><span\x20style=\x22font-size:12.0pt;\x22>Muromonab-CD3</span></p>','optionsContainer','<p><span\x20style=\x22font-size:12.0pt;\x22>Cardiac\x20failure</span></p>','ObuAK','AmLOo','evZxo','timed_study','<p><span\x20style=\x22font-size:12.0pt;\x22>Ganciclovir</span></p>','explanationVideoPlayer','viQqQ','MLfGp','filter','vsYtQ','CmVWp','<ul>\x0d\x0a<li><strong><em>Hand\x20foot\x20syndrome\x20or\x20palmar-plantar\x20erythrodysesthesia</em></strong><em>\x20consists\x20of\x20<strong>erythema,\x20desquamation,\x20pain\x20and\x20sensitivity\x20to\x20touch\x20of\x20the\x20palms\x20and\x20soles</strong>.</em></li>\x0d\x0a<li><strong><em><u>Drugs\x20commonly\x20implicated\x20are:</u></em></strong>\x0d\x0a<ul>\x0d\x0a<li><strong><em>Capecitabine</em></strong></li>\x0d\x0a<li><strong><em>5-Fluorouracil</em></strong></li>\x0d\x0a<li><strong><em>Cytarabine</em></strong></li>\x0d\x0a<li><strong><em>Pemetrexed</em></strong></li>\x0d\x0a<li><strong><em>Doxorubicin</em></strong></li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a</ul>\x0d\x0a<p><strong>Option\x20A:</strong><em>\x20Cisplatin\x20is\x20associated\x20with\x20<strong>nausea\x20and\x20vomiting\x20</strong>(maximum\x20among\x20all\x20anti-cancer\x20drugs).\x20It\x20is\x20mild\x20bone\x20marrow\x20suppressants\x20and\x20are\x20nephrotoxic,\x20ototoxic\x20as\x20well\x20as\x20neurotoxic.</em></p>\x0d\x0a<p><strong>Option\x20B</strong><em>:\x20Vincristine\x20is\x20associated\x20with\x20development\x20<strong>of\x20peripheral\x20neuropathy</strong>\x20in\x20first\x20few\x20weeks\x20of\x20therapy\x20characterised\x20by\x20paresthesias\x20and\x20loss\x20of\x20reflexes</em></p>\x0d\x0a<p><strong>Option\x20D</strong><em>:\x20Mitomycin\x20C\x20is\x20associated\x20with\x20bone\x20marrow\x20and\x20g.i.t.\x20are\x20the\x20primary\x20targets\x20of\x20toxicity.\x20<strong>Myelosuppression\x20is\x20typically\x20delayed.</strong>\x20A\x20haemolytic-uremic\x20syndrome\x20is\x20reported.</em></p>\x0d\x0a<p><strong><u>Key\x20takeaway</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>Capecitabine\x20is\x20associated\x20with\x20<strong>Hand\x20foot\x20syndrome\x20or\x20palmar-plantar\x20erythrodysesthesia</strong></em></li>\x0d\x0a</ul>','study','WsqNv','DqOMa','nMyyS','24cGMvaf','prevBtn','npmwr','24104951oBTlQy','\x22\x20controls\x20class=\x22w-full\x22></audio></div>','You\x20have\x20reached\x20the\x20end\x20of\x20the\x20quiz.\x20Would\x20you\x20like\x20to\x20submit\x20your\x20answers\x20now?','explanation_audio_hin','kcKtv','qlHmF','jXGdD','TymYw','Marked','TSLhN','now','border-red-500','WkJZW','notAttempted','.m3u8','<p><span\x20style=\x22font-size:12.0pt;\x22>Actinomycin\x20D</span></p>','QRP','cANis','SxLMa','choices','kvJsW','<p><em><u>Among\x20the\x20anticancer\x20drugs,\x20bleomycin\x20most\x20commonly\x20causes\x20pulmonary\x20toxicity,\x20mainly\x20interstitial\x20pneumonitis\x20followed\x20by\x20pulmonary\x20fibrosis.\x20</u></em></p>\x0d\x0a<p><em><u>The\x20mortality\x20associated\x20with\x20bleomycin\x20pulmonary\x20toxicity\x20is\x20very\x20high\x20(about\x2050%).</u></em></p>\x0d\x0a<p><strong><em><u>Bleomycin</u></em></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>It\x20is\x20a\x20glycopeptide\x20drug\x20that\x20acts\x20in\x20the<strong>\x20G2\x20phase</strong>\x20by\x20causing\x20DNA\x20strand\x20breakage\x20and\x20free\x20radical\x20formation.</em></li>\x0d\x0a<li><em>It\x20can\x20result\x20in\x20:</em>\x0d\x0a<ul>\x0d\x0a<li><strong><em>Cutaneous\x20toxicity\x20</em></strong><em>(hyperpigmentation,\x20hyperkeratosis,\x20erythema\x20and\x20ulcers)</em></li>\x0d\x0a<li><strong><em>Pneumonitis</em></strong></li>\x0d\x0a<li><strong><em>Pulmonary\x20fibrosis,\x20</em></strong></li>\x0d\x0a<li><em>Hypersensitivity\x20and\x20</em></li>\x0d\x0a<li><strong><em>Mucocutaneous\x20reactions\x20</em></strong><em>(particularly\x20flagellated\x20pigmentation\x20of\x20skin).</em></li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a<li><strong><em>It\x20causes\x20necrosis\x20of\x20type\x20I\x20pneumocytes\x20that\x20results\x20in\x20compensatory\x20hyperplasia\x20of\x20type\x20II\x20pneumocytes.</em></strong></li>\x0d\x0a<li><strong><em>Bleomycin\x20is\x20metabolized\x20by\x20bleomycin\x20hydrolase,\x20whose\x20concentration\x20is\x20less\x20in\x20skin\x20and\x20lungs\x20(thus\x20major\x20organs\x20involved\x20in\x20toxicity).\x20<br><img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/b8e58c25-0df7-4551-b193-3eb3b1be06491.jpg\x22><br><img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2249d6b49-ad29-490e-a881-54115fde51b00.jpg\x22></em></strong></li>\x0d\x0a</ul>\x0d\x0a<p><strong>Option\x20A</strong><em>:\x20Cyclophosphamide\x20results\x20in\x20<strong>hemorrhagic\x20cystitis,\x20</strong>cardiac\x20dysfunction,\x20pulmonary\x20toxicity\x20and\x20syndrome\x20of\x20inappropriate\x20ADH\x20secretion</em></p>\x0d\x0a<p><strong>Option\x20B</strong>:\x20<em>Doxorubicin\x20is\x20the\x20Anthracycline\x20anticancer\x20drugs\x20that\x20have\x20the\x20highest\x20risk\x20of\x20cardiac\x20toxicity,\x20it\x20can\x20cause\x20a\x20<strong>dose\x20dependent\x20dilated\x20cardiomyopathy\x20associated\x20with\x20a\x20potentially\x20fatal\x20cardiac\x20failure</strong></em></p>\x0d\x0a<p><strong>Option\x20C</strong><em>:\x20Vincristine\x20is\x20associated\x20with\x20development\x20of\x20<strong>peripheral\x20neuropathy</strong>\x20in\x20first\x20few\x20weeks\x20of\x20therapy\x20characterised\x20by\x20paresthesias\x20and\x20loss\x20of\x20reflexes</em></p>\x0d\x0a<p><strong><u>Key\x20takeaway</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><strong><em>Among\x20the\x20anticancer\x20drugs,\x20bleomycin\x20most\x20commonly\x20causes\x20pulmonary\x20toxicity,\x20mainly\x20interstitial\x20pneumonitis\x20followed\x20by\x20pulmonary\x20fibrosis.\x20The\x20mortality\x20associated\x20with\x20bleomycin\x20pulmonary\x20toxicity\x20is\x20very\x20high\x20(about\x2050%).</em></strong></li>\x0d\x0a</ul>','hidden','sAitB','floor','alLup','notAttemptedResult','kbTYn','classList','dTRcn','isArray','nRLCq','CvqVd','JqoHh','oHkrc','NdFUQ','wjxOP','totalAttempted','PdlRJ','question_images','UReic','toString','Not\x20Attempted','LSIxR','<p><em><u>Valacyclovir\x20is\x20related\x20to\x20acyclovir,\x20both\x20of\x20which\x20are\x20used\x20for\x20the\x20treatment\x20of\x20oral\x20and\x20genital\x20herpes\x20in\x20immunocompetent\x20individuals.</u></em></p>\x0d\x0a<ul>\x0d\x0a<li><strong><em><u>Valacyclovir\x20:</u></em></strong></li>\x0d\x0a<li><em>It\x20is\x20a\x20<strong>valyl\x20ester\x20prodrug\x20of\x20acyclovir\x20with\x20improved\x20oral\x20bioavailability</strong></em>\x20<em>due\x20to\x20active\x20transport\x20by\x20peptide\x20transporters\x20in\x20the\x20intestine.</em></li>\x0d\x0a<li><em>During\x20passage\x20through\x20intestine\x20and\x20liver,\x20it\x20is\x20<strong>completely\x20converted\x20to\x20acyclovir\x20</strong>in\x20the\x20first\x20passage\x20by\x20esterases</em><em>.\x20Valaciclovir\x20is\x20<strong>excreted\x20in\x20urine.</strong></em></li>\x0d\x0a<li><strong><em>Thus,\x20&gt;3\x20fold\x20higher\x20plasma\x20levels\x20of\x20acyclovir\x20</em></strong><em>are\x20obtained\x20improving\x20clinical\x20efficacy\x20in\x20certain\x20conditions</em><em>.</em></li>\x0d\x0a<li><strong><em>It\x20is\x20the\x20drug\x20of\x20choice\x20in\x20herpes\x20zoster.</em></strong></li>\x0d\x0a</ul>\x0d\x0a<p><strong><em>Option\x20A,\x20C\x20&amp;\x20D</em></strong><em>:\x20All\x20of\x20these\x20agents\x20are\x20not\x20the\x20preferred\x20choice\x20of\x20drugs\x20for\x20herpes\x20zoster.</em></p>\x0d\x0a<p><strong><u>Key\x20Takeaway</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>Valacyclovir\x20is\x20used\x20for\x20the\x20treatment\x20of\x20<strong>oral\x20and\x20genital\x20herpes\x20in\x20immunocompetent\x20individuals</strong>.</em></li>\x0d\x0a</ul>','QMEHZ','customQuizData','bDYSN','questionMedia','modeModal','KFILv','FtRyg','JjIYr','lqsTG','UnShH','<div\x20class=\x22mt-4\x22><video\x20id=\x22review-video-','HSvcR','textContent','233223JkiKvm','ijgZW','markReviewText','hPzGf','JnNWu','querySelectorAll','RquIJ','fYbWZ','bookmarkedQuestions','Bookmark','qDLBM','IiZph','eqTis','naiKQ','aykiW','jGozF','FDjFa','slGNa','VxNgf','bookmarked','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2047-year-old\x20man\x20with\x20non-Hodgkin\x20lymphoma\x20was\x20admitted\x20to\x20the\x20hospital\x20to\x20receive\x20his\x20fourth\x20cycle\x20of\x20CHOP\x20(cyclophosphamide,\x20doxorubicin,\x20vincristine\x20and\x20prednisone)\x20regimen\x20plus\x20rituximab.\x20Physical\x20examination\x20revealed\x20tachycardia,\x20shortness\x20of\x20breath\x20that\x20worsened\x20on\x20lying,\x20neck\x20vein\x20distention,\x20pulmonary\x20rales\x20and\x20ankle\x20edema.\x20Which\x20of\x20the\x20following\x20drugs\x20most\x20likely\x20caused\x20these\x20adverse\x20effects?</span></p>','FWXVU','nZSbI','(((.+)+)+)+$','xksUU','obkmm','fhUOg','-600\x20text-white\x22>','qSYTW','ZGJrh','totalTimeResult','GXkNK','TVixB','AFYyy','<p><span\x20style=\x22font-size:12.0pt;\x22>Pertuzumab</span></p>','16045aWlejs','hfpHz','testModeLegend','performanceModal','UYpnD','data-option-index','hierarchy','scQfq','DiOjL','nav-btn-answered','studyModeLegend','solutionContainer','answered','question_video','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish:</p><audio\x20src=\x22','COqcF','pCbbV','DocTutorial','href','src','JbGyS','jMxDu','xMRGY','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2032-year-old\x20woman\x20complained\x20to\x20his\x20physician\x20of\x20a\x20sudden\x20increase\x20in\x20her\x20heart\x20rate.\x20Four\x20days\x20earlier,\x20the\x20woman,\x20who\x20had\x20recently\x20returned\x20from\x20a\x20trip\x20to\x20Uganda,\x20was\x20hospitalized\x20with\x20the\x20presumptive\x20diagnosis\x20of\x20malaria.\x20The\x20Plasmodium\x20vivax\x20infection\x20was\x20confirmed,\x20and\x20the\x20patient\x20started\x20an\x20appropriate\x20therapy.\x20An\x20electrocardiogram\x20led\x20to\x20the\x20diagnosis\x20of\x20torsades\x20de\x20pointes.\x20Which\x20of\x20the\x20following\x20drugs\x20most\x20likely\x20caused\x20the\x20patient\x27s\x20arrhythmia?</span></p>','toLowerCase','gXHyK','YeuZl','<ul>\x0d\x0a<li><strong><em>A\x20high-dose\x20glucocorticoid\x20(usually\x20intravenous\x20methylprednisolone)\x20is\x20considered\x20first-line\x20therapy\x20for\x20acute\x20rejection\x20because\x20it\x20works\x20very\x20quickly\x20in\x20decreasing\x20lymphocyte\x20responsiveness\x20and\x20can\x20reverse\x20at\x20least\x2075%\x20of\x20acute\x20rejection\x20episodes</em></strong><em>.</em></li>\x0d\x0a<li><strong><em>Muromonab-CD3\x20is\x20usually\x20reserved\x20for\x20steroid\x20resistant\x20rejection.</em></strong></li>\x0d\x0a</ul>\x0d\x0a<p><strong><em><u>Muromonab</u></em></strong><em>\x20<strong><u>CD3</u></strong></em></p>\x0d\x0a<ul>\x0d\x0a<li><em>It\x20is\x20<u>now\x20primarily\x20used\x20for\x20acute\x20transplant\x20rejection\x20reaction,\x20particularly\x20in\x20steroid-resistant\x20cases</u>.</em></li>\x0d\x0a<li><em>Daily\x20i.v.\x20injection\x20of\x20<u>muromonab\x20CD3\x20is\x20given\x20for\x202\x20weeks\x20along\x20with\x20corticosteroids\x20and\x20other\x20immunosuppressants</u>.</em></li>\x0d\x0a<li><em>It\x20has\x20also\x20been\x20used\x20to\x20deplete\x20T\x20cells\x20from\x20the\x20donor\x20bone\x20marrow\x20before\x20transplantation.</em></li>\x0d\x0a<li><strong><em>Initial\x20doses\x20of\x20muromonab\x20CD3\x20are\x20associated\x20with</em></strong></li>\x0d\x0a<li><em>\x27<strong><u>Cytokine\x20release\x20syndrome\x27</u></strong><u>\x20with\x20flu-like\x20symptoms,\x20viz.\x20chills,\x20rigor,\x20high\x20fever,\x20wheezing,\x20malaise,\x20etc.\x20which\x20is\x20due\x20to\x20release\x20of\x20TNF&alpha;,\x20ILs\x20and\x20interferon.</u></em></li>\x0d\x0a</ul>\x0d\x0a<p><strong>Option\x20A</strong>:\x20Because\x20prednisone\x20failed\x20to\x20resolve\x20the\x20rejection,\x20administration\x20of\x20another\x20steroid\x20would\x20be\x20irrational.</p>\x0d\x0a<p><strong>Option\x20C</strong>:\x20Aldesleukin\x20is\x20an\x20immunostimulant,\x20not\x20an\x20immunosuppressive\x20drug.</p>\x0d\x0a<p><strong>Option\x20D</strong>:\x20Because\x20a\x20cytotoxic\x20drug\x20failed\x20to\x20prevent\x20rejection,\x20the\x20choice\x20of\x20other\x20cytotoxic\x20drugs\x20is\x20not\x20appropriate.</p>\x0d\x0a<p><strong><u>Key\x20Takeaway</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>Muromonab-CD3\x20is\x20usually\x20reserved\x20for\x20steroid\x20resistant\x20rejection.</em></li>\x0d\x0a</ul>','vbXPC','reload','ARWcj','addEventListener','bXwqB','oNinP','DT1293504','tVvau','WZmSt','xRusn','eMjrB','No\x20questions\x20available\x20for\x20this\x20quiz.','<p><em><u>Ganciclovir\x20is\x20a\x20drug\x20of\x20choice\x20for\x20cytomegalovirus\x20(CMV)\x20infections.\x20</u></em></p>\x0d\x0a<p><em><u>The\x20dose-limiting\x20toxicity\x20of\x20both\x20zidovudine\x20and\x20ganciclovir\x20is\x20bone\x20marrow\x20suppression;\x20<strong>therefore,\x20anemia\x20and\x20neutropenia\x20can\x20be\x20predicted\x20from\x20the\x20concurrent\x20administration\x20of\x20ganciclovir\x20and\x20zidovudine.</strong></u></em></p>\x0d\x0a<p><strong><em>Systemic\x20toxicity\x20of\x20ganciclovir\x20is\x20high\x20</em></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>Bone\x20marrow</em><em>\x20suppression\x20</em></li>\x0d\x0a<li><em>Fever</em><em>,\x20Rash</em></li>\x0d\x0a<li><em>Vomiting\x20</em></li>\x0d\x0a<li><em>Neuropsychiatric\x20disturbances</em></li>\x0d\x0a<li><em>Retinal\x20Detachments\x20&amp;\x20Cataract\x20if\x20used\x20Intravitreal.</em></li>\x0d\x0a</ul>\x0d\x0a<p>Therefore,\x20<em><u>use\x20is\x20restricted\x20to\x20prophylaxis\x20and\x20treatment\x20of\x20severe\x20CMV\x20infections\x20(pneumonia/colitis/retinitis)\x20which\x20occur\x20in\x20immunocompromised\x20(AIDS,\x20transplant\x20recipient)\x20patients</u></em>.\x20<br><img\x20class=\x22w-100\x22\x20style=\x22height:\x20auto;\x20display:\x20block;\x20vertical-align:\x20middle;\x20border:\x200;\x22\x20src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024122335344f4d-6f50-46ad-b9d1-bfd6622cead1.jpg\x22>\x0d\x0a<p><strong>Option\x20B\x20&amp;\x20C</strong>:\x20<strong>Retinal\x20detachment\x20and\x20cataracts\x20</strong>are\x20adverse\x20effects\x20of\x20ganciclovir\x20that\x20can\x20occur\x20<strong>following\x20intravitreal\x20</strong>administration\x20of\x20the\x20drug\x20for\x20CMV\x20retinitis.\x20They\x20<strong>do\x20not\x20occur\x20</strong>when\x20the\x20drug\x20is\x20administered\x20<strong>intravenously</strong>\x20for\x20systemic\x20anti-CMV\x20therapy.</p>\x0d\x0a<p><strong>Option\x20D:\x20Sexual\x20dysfunction\x20is\x20not\x20an\x20adverse\x20effect\x20</strong>of\x20the\x20drugs\x20the\x20patient\x20has\x20been\x20receiving.</p>\x0d\x0a<p><strong><u>Key\x20Takeaway</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>The\x20dose-limiting\x20toxicity\x20of\x20ganciclovir\x20is\x20<strong>bone\x20marrow\x20suppression,\x20</strong>hence\x20manifested\x20as\x20<strong>anemia\x20and\x20neutropenia\x20if\x20administered\x20along\x20with\x20zidovudine.\x20</strong></em></li>\x0d\x0a</ul>','Previous\x20progress\x20cleared.','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2031-year-old\x20man\x20with\x20AIDS\x20was\x20recently\x20diagnosed\x20with\x20cytomegalovirus\x20pneumonia.\x20The\x20patient\x27s\x20current\x20medications\x20included\x20zidovudine,\x20didanosine\x20and\x20atazanavir.\x20Intravenous\x20therapy\x20with\x20ganciclovir\x20was\x20started.\x20Which\x20of\x20the\x20following\x20adverse\x20effects\x20would\x20be\x20predicted\x20to\x20be\x20most\x20likely\x20to\x20occur\x20due\x20to\x20the\x20concurrent\x20administration\x20of\x20ganciclovir\x20and\x20the\x20antiretroviral\x20drugs?</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Ceftriaxone</span></p>','nav-btn-marked-review','info','SjjWu','className','Cwykx','inPfb','guIUF','SDoTL','ClSzT','index.html','hsZBr','pmlhh','pWaaO','strokeDashoffset','video[data-src]','constructor','QqEbq','vvTNB','2|0|1|4|3|5','ozWva','aQWeh','name','exception','lkvfq','<p><span\x20style=\x22font-size:12.0pt;\x22>Capecitabine\x20</span></p>','resume','RciAb','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2033-year-old\x20woman\x20with\x20AIDS\x20was\x20recently\x20diagnosed\x20with\x20cytomegalovirus\x20retinitis.\x20The\x20ophthalmologist\x20prescribed\x20a\x20drug\x20that\x20must\x20be\x20phosphorylated\x20first\x20by\x20virus-specific\x20enzymes,\x20then\x20by\x20host\x20cell\x20enzymes\x20to\x20become\x20active.\x20Which\x20of\x20the\x20following\x20drugs\x20was\x20most\x20likely\x20given?</span></p>','QxarX','getAttribute','Wzgrn','gTIae','<p><span\x20style=\x22font-size:12.0pt;\x22>Valacyclovir</span></p>','TaQHG','YkKeH','dQBwM','qbaaj','pxoll','uKcsk','VplfO','KnoDv','pZQoz','XtlOc','DT1293501','ymwFn','gchxv','split','custom_quiz.html','</span><span>','questionStates','xVLfC','<p><span\x20style=\x22font-size:12.0pt;\x22>Hypotension</span></p>','quizPerformanceData','\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','getItem','button','CbhKX','VgnVC','WkHlA','jefqY','parse','XsvHz','correctAnswers','DYhiT','EeDmI','VZtSK','PCVlY','status','<p><span\x20style=\x22font-size:12.0pt;\x22>Prednisone</span></p>','GfPjN','18XExRtr','vTGCU','getElementById','YIgpT','dEhAn','<p><span\x20style=\x22font-size:12.0pt;\x22>Azidothymidine</span></p>','4|3|1|5|2|0','<p><span\x20style=\x22font-size:12.0pt;\x22>Doxorubicin</span></p>','log','bfWHu','map','flex','cJvFZ','WxqzX','No\x20solution\x20available.','contains','oDnnB','reduce','UXOoo','not_attempted','padStart','KJxrm','totalQuestions','prototype','return\x20(function()\x20','<p><span\x20style=\x22font-size:12.0pt;\x22>Sexual\x20dysfunction</span></p>','markedForReview','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English:</p><audio\x20src=\x22','canPlayType','</span></div>','Are\x20you\x20sure\x20you\x20want\x20to\x20retake\x20the\x20quiz?\x20This\x20will\x20reset\x20all\x20your\x20answers.','round','<p><span\x20style=\x22font-size:12.0pt;\x22>Oral\x20Chloroquine,\x20sulfadoxine,\x20pyrimethamine</span></p>','DT1293603','<p><span\x20style=\x22font-size:12.0pt;\x22>Mitomycin\x20C</span></p>','strokeDasharray','BSsxs','OcsTn','XdWIT','<p><span\x20style=\x22font-size:12.0pt;\x22>Ketoconazole</span></p>','correctResult','OuBxM','XYDie','ZxVFl','GEMHe','<ul>\x0d\x0a<li><strong><em><u>Severe\x20and\x20complicated\x20falciparum\x20malaria</u></em></strong>\x0d\x0a<ul>\x0d\x0a<li><em><u>Parenteral\x20artemisinins\x20are\x20highly\x20effective\x20and\x20are\x20the\x20drugs\x20of\x20choice\x20irrespective\x20of\x20CQ\x20resistance\x20status</u></em><em>.</em></li>\x0d\x0a<li><em>Quinine\x20is\x20used\x20only\x20as\x20an\x20alternative\x20when\x20artemisinins\x20cannot\x20be\x20used.</em></li>\x0d\x0a<li><em>Quinine\x20(i.v.)\x20continues\x20to\x20be\x20the\x20drug\x20used\x20for\x20severe\x20falciparum\x20malaria\x20during\x201st\x20trimester\x20of\x20pregnancy,\x20because\x20safety\x20of\x20artemisinins\x20is\x20not\x20yet\x20proven.</em></li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a</ul>\x0d\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412243e7f55f5-8884-49fc-b932-45e4bb03dde1.jpg\x22>\x0d\x0a<ul>\x0d\x0a<li><strong><em><u>Severe\x20and\x20complicated\x20falciparum\x20malaria</u></em></strong>\x0d\x0a<ul>\x0d\x0a<li><strong><em>Parenteral\x20artemisinins\x20are\x20highly\x20effective\x20and\x20are\x20the\x20drugs\x20of\x20choice</em></strong></li>\x0d\x0a<li><em><u>Quinine\x20infused\x20i.v.\x20had\x20been\x20the\x20drug\x20of\x20choice\x20for\x20severe\x20and\x20complicated\x20malaria</u></em><em>,\x20including\x20cerebral\x20malaria,\x20but\x20<u>now\x20i.v./i.m.\x20artemisinins\x20are\x20preferred,\x20while\x20quinine\x20is\x20used\x20only\x20as\x20an\x20alternative\x20when\x20artemisinins\x20cannot\x20be\x20used.</u></em></li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a<li><strong><em><u>Artesunate\x20(i.v.)\x20offers\x20several\x20advantages:</u></em></strong>\x0d\x0a<ul>\x0d\x0a<li><strong><em>It\x20causes\x20faster\x20parasite\x20clearance\x20than\x20i.v.\x20quinine.</em></strong></li>\x0d\x0a<li><strong><em>It\x20is\x20safer\x20and\x20better\x20tolerated\x20than\x20i.v.\x20quinine.</em></strong></li>\x0d\x0a<li><strong><em>Its\x20dosing\x20schedule\x20is\x20simpler.</em></strong></li>\x0d\x0a<li><strong><em>Evidence\x20from\x20clinical\x20trial\x20indicates\x20higher\x20efficacy\x20and\x20lower\x20mortality</em></strong><strong>.</strong></li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a</ul>\x0d\x0a<p><strong>Options\x20A,\x20B\x20&amp;\x20D</strong>:\x20<em>All\x20given\x20agents\x20are\x20not\x20the\x20preferred\x20choice\x20of\x20drugs\x20for\x20Severe\x20and\x20complicated\x20falciparum\x20malaria.\x20All\x20are\x20primarily\x20preferred\x20for\x20P.vivax\x20infections</em></p>\x0d\x0a<p><strong><u>Key\x20Takeaway</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>Parenteral\x20artemisinins\x20are\x20highly\x20effective\x20and\x20are\x20the\x20drugs\x20of\x20choice\x20for\x20<u>Severe\x20and\x20complicated\x20falciparum\x20malaria</u></em></li>\x0d\x0a</ul>','HwOJx','bXCTz','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English\x20Explanation:</p><audio\x20src=\x22','Progress\x20loaded.','devLf','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2056\x20year\x20old\x20male\x20patient\x20with\x20AIDS\x20was\x20being\x20treated\x20with\x20multiple\x20drugs,\x20including\x20AZT,\x20lamivudine,\x20indinavir,\x20ketoconazole\x20and\x20cotrimoxazole.\x20Later\x20he\x20came\x20to\x20the\x20medicine\x20department\x20with\x20breast\x20hypertrophy,\x20central\x20adiposity,\x20hyperlipidemia,\x20insulin\x20resistance,\x20and\x20nephrolithiasis.\x20If\x20these\x20side\x20effects\x20are\x20related\x20to\x20his\x20drug\x20treatment,\x20which\x20of\x20the\x20following\x20is\x20the\x20most\x20likely\x20implicated\x20drug?</span></p>','BVzeB','<p><span\x20style=\x22font-size:12.0pt;\x22>Cyclophosphamide</span></p>','XlTYS','olXpS','toISOString','appendChild','jLgvO','SGjNA','vseCJ','incorrectAnswers','MBcrP','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22mb-4\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22flex\x20justify-between\x20items-center\x20mb-3\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h4\x20class=\x22text-lg\x20font-bold\x20text-white\x22>Question\x20','fvGsh','sXSeI','3498xtSvFF','style','<p><span\x20style=\x22font-size:12.0pt;\x22>Hypokalemia</span></p>','Mppok','TrGhO','bind','zWSVR','</span>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20mb-4\x22>','OFrDY','Are\x20you\x20sure\x20you\x20want\x20to\x20submit\x20the\x20quiz?','HQhFh','yRPiL','KARBs','ZyfmF','dPhHb','display','VSgbL','eMFqH','fFUQL','DT1293605','location','enGaG','block','WMmzj','{}.constructor(\x22return\x20this\x22)(\x20)','\x22\x20data-src=\x22','table','<p><span\x20style=\x22font-size:12.0pt;\x22>Vincristine</span></p>','correct_choice_id','fromCharCode','quizSidebar','totalTime','solutionText','fill','VZgLQ','<p><em><u>The\x20patient\x27s\x20paresthesias\x20and\x20loss\x20of\x20reflexes\x20are\x20signs\x20of\x20vincristine\x20peripheral\x20neuropathy,\x20which\x20often\x20appears\x20within\x20the\x20first\x20few\x20weeks\x20of\x20therapy.\x20</u></em></p>\x0d\x0a<p><em>Areflexia\x20is\x20common\x20in\x20patients\x20treated\x20with\x20high\x20cumulative\x20doses.\x20</em></p>\x0d\x0a<p><strong><em>Vincristine</em></strong><em>\x20causes\x20a\x20<strong>dose-limiting\x20neurotoxicity</strong>\x20but\x20is\x20a\x20mild\x20myelosuppression\x20,\x20whereas\x20<strong>vinblastine</strong>\x20causes\x20negligible\x20neurotoxicity\x20but\x20gives\x20rise\x20to\x20a\x20severe,\x20dose-limiting\x20<strong>myelosuppression</strong>.</em></p>\x0d\x0a<p>Vin<strong>C</strong>ristine\x20-\x20<strong>C</strong>NS</p>\x0d\x0a<p>Vin<strong>B</strong>Lastine\x20-\x20<strong>Blast\x20</strong>Cell\x20Arrest.</p>\x0d\x0a<ul>\x0d\x0a<li><strong><em><u>Vincristine\x20(oncovin)</u></em></strong>\x0d\x0a<ul>\x0d\x0a<li><em>It\x20is\x20a\x20rapidly\x20acting\x20drug,\x20<u>very\x20useful\x20for\x20inducing\x20remission\x20in\x20<strong>childhood\x20acute\x20lymphoblastic\x20leukaemia.</strong></u></em></li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a<li><em>Other\x20indications\x20are</em>\x0d\x0a<ul>\x0d\x0a<li><strong><em>Acute\x20myeloid\x20leukaemia,\x20</em></strong></li>\x0d\x0a<li><em>Hodgkin\x27s\x20disease,</em></li>\x0d\x0a<li><em>Wilms\x27\x20tumour,\x20</em></li>\x0d\x0a<li><em>Ewing\x27s\x20sarcoma,\x20</em></li>\x0d\x0a<li><em>Neuroblastoma</em></li>\x0d\x0a<li><em>Carcinoma\x20lung.</em></li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a<li><strong><em><u>Prominent\x20adverse\x20effects</u></em></strong>\x0d\x0a<ul>\x0d\x0a<li><strong><em>Peripheral\x20neuropathy\x20</em></strong></li>\x0d\x0a<li><em>Ataxia,\x20</em></li>\x0d\x0a<li><em>Nerve\x20palsies,\x20</em></li>\x0d\x0a<li><strong><em>Autonomic\x20dysfunction\x20</em></strong></li>\x0d\x0a<li><em>(postural\x20hypotension,\x20paralytic\x20ileus,\x20urinary\x20retention)</em></li>\x0d\x0a<li><em>Bone\x20marrow\x20depression</em></li>\x0d\x0a<li><strong><em>Syndrome\x20of\x20inappropriate\x20secretion\x20of\x20ADH\x20(SIADH)\x20can\x20occur</em></strong></li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a</ul>\x0d\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024122492613cce-09ee-483d-b203-66a5bb04e4aa.jpg\x22>\x0d\x0a<p><strong>Option\x20B</strong><em>:\x20Prednisone\x20is\x20associated\x20with\x20range\x20of\x20side\x20effects\x20including\x20<strong>opportunistic\x20infection\x20</strong>but\x20not\x20peripheral\x20neuropathy</em></p>\x0d\x0a<p><strong>Option\x20C<em>:\x20</em></strong><em>Adverse\x20effects\x20of\x20methotrexate\x20<strong>are\x20bone\x20marrow\x20suppression\x20and\x20mucositis.</strong></em></p>\x0d\x0a<p><strong>Option\x20D<em>:\x20</em></strong><em>Dose\x20limiting\x20toxicity\x20of\x206-mercaptopurine\x20(6-MP)\x20is\x20<strong>bone\x20marrow\x20suppression\x20but\x20hepatotoxicity\x20can\x20also\x20result.</strong></em></p>\x0d\x0a<p><strong><u>Key\x20takeaway</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>Vincristine\x20is\x20associated\x20with\x20<strong>development\x20of\x20peripheral\x20neuropathy</strong>\x20in\x20the\x20first\x20few\x20weeks\x20of\x20therapy\x20characterised\x20by\x20paresthesias\x20and\x20loss\x20of\x20reflexes.</em></li>\x0d\x0a</ul>','solutionImages','div','title','tSetD','QkwZS','SIlPm','HAnom','border-green-500','qNcTv','XtmRT','selectedAnswer','not-attempted','QnBDC','keydown','endsWith','quizHierarchy','<p><span\x20style=\x22font-size:12.0pt;\x22>Vincristine\x20</span></p>'];_0x5dfe=function(){return _0x243d85;};return _0x5dfe();}function goBack(){const _0x26b61d=_0x2af812,_0x4afde8={'ABOFP':function(_0x5879c4){return _0x5879c4();},'caSCv':'index.html'};if(!isQuizCompleted)_0x4afde8['ABOFP'](saveProgress);window['location'][_0x26b61d(0x1b0)]=document['referrer']||_0x4afde8['caSCv'];}function selectMode(_0x26d4fd){const _0x455ad8=_0x2af812,_0x28dfac={'BSsxs':'modeModal','LsgUu':function(_0x24b024){return _0x24b024();}};currentMode=_0x26d4fd,document['getElementById'](_0x28dfac[_0x455ad8(0x234)])[_0x455ad8(0x253)][_0x455ad8(0x261)]=_0x455ad8(0x30b),_0x28dfac['LsgUu'](initializeQuiz);}function initializeQuiz(){const _0x5e72ef=_0x2af812,_0x47f35f={'izdlW':_0x5e72ef(0x1dc),'WMmzj':_0x5e72ef(0x226),'xRusn':function(_0x2368be,_0x26b3aa){return _0x2368be+_0x26b3aa;},'wLHdJ':_0x5e72ef(0x346),'LEiDr':_0x5e72ef(0x285),'GbBLa':_0x5e72ef(0x2c8),'nzLtg':_0x5e72ef(0x39a),'nMyyS':_0x5e72ef(0x308),'gGlkO':_0x5e72ef(0x3a1),'ugZuW':function(_0x4261b4,_0x5295bb){return _0x4261b4===_0x5295bb;},'CmVWp':_0x5e72ef(0x2df),'lmEjq':_0x5e72ef(0x2da),'dTRcn':'none','FDjFa':'block','Mbrfy':_0x5e72ef(0x444),'pmlhh':_0x5e72ef(0x2e8),'VgnVC':_0x5e72ef(0x21b),'ExzKh':_0x5e72ef(0x3d5),'laGqj':function(_0x259de0,_0x42c7a){return _0x259de0!==_0x42c7a;},'ymwFn':'IbHHy','VnUNz':_0x5e72ef(0x2a5),'JGEqd':_0x5e72ef(0x3fb),'hZayH':function(_0x1f238f,_0x53ba5c){return _0x1f238f(_0x53ba5c);},'UgKSb':function(_0x101ec6,_0x869e7d){return _0x101ec6>=_0x869e7d;},'RvhFT':function(_0x4de0d2,_0x26e052){return _0x4de0d2<_0x26e052;},'wwDyM':function(_0x2427fc){return _0x2427fc();},'cWclI':function(_0x4d6d82){return _0x4d6d82();},'LnHuO':function(_0x4bcb4c){return _0x4bcb4c();}};quizStartTime=Date[_0x5e72ef(0x3ef)]();const _0x5992f4=document[_0x5e72ef(0x212)](_0x47f35f[_0x5e72ef(0x321)]),_0x41bcc6=document['getElementById'](_0x47f35f[_0x5e72ef(0x3e1)]),_0x207d62=document[_0x5e72ef(0x212)](_0x47f35f['gGlkO']),_0x414e6d=_0x47f35f['ugZuW'](currentMode,_0x5e72ef(0x29e))||currentMode===_0x47f35f[_0x5e72ef(0x3dc)];document['getElementById'](_0x47f35f['lmEjq'])[_0x5e72ef(0x253)][_0x5e72ef(0x261)]=_0x414e6d?_0x47f35f[_0x5e72ef(0x402)]:_0x47f35f[_0x5e72ef(0x42f)],document[_0x5e72ef(0x212)](_0x5e72ef(0x44c))['style'][_0x5e72ef(0x261)]=_0x414e6d?_0x47f35f[_0x5e72ef(0x402)]:_0x47f35f[_0x5e72ef(0x42f)],document[_0x5e72ef(0x212)](_0x47f35f['Mbrfy'])[_0x5e72ef(0x253)]['display']=_0x414e6d?_0x5e72ef(0x268):_0x47f35f[_0x5e72ef(0x402)],document['getElementById'](_0x47f35f[_0x5e72ef(0x1d5)])[_0x5e72ef(0x253)][_0x5e72ef(0x261)]=_0x414e6d?_0x47f35f['FDjFa']:_0x47f35f[_0x5e72ef(0x402)],_0x5992f4['style']['display']=_0x414e6d?_0x47f35f['dTRcn']:_0x5e72ef(0x21b),_0x41bcc6[_0x5e72ef(0x253)][_0x5e72ef(0x261)]=_0x414e6d?_0x47f35f['VgnVC']:_0x47f35f[_0x5e72ef(0x402)],_0x207d62[_0x5e72ef(0x253)][_0x5e72ef(0x261)]=_0x414e6d?_0x47f35f[_0x5e72ef(0x203)]:_0x47f35f[_0x5e72ef(0x402)];if(currentMode===_0x47f35f[_0x5e72ef(0x2ca)]||currentMode==='timed_exam'){if(_0x47f35f[_0x5e72ef(0x2e6)](_0x47f35f[_0x5e72ef(0x1f6)],'nhTko'))document[_0x5e72ef(0x212)](_0x47f35f[_0x5e72ef(0x2c6)])['classList']['remove'](_0x47f35f['JGEqd']);else{const _0x3f2915=_0x47f35f[_0x5e72ef(0x36b)][_0x5e72ef(0x1f8)]('|');let _0x540469=0x0;while(!![]){switch(_0x3f2915[_0x540469++]){case'0':_0x170133=_0x50ce35[_0x5e72ef(0x1df)];continue;case'1':_0x5cb557=_0x25d9e9[_0x5e72ef(0x448)];continue;case'2':_0x551ecc=_0x4f4f26[_0x5e72ef(0x2ae)];continue;case'3':_0x5edbb0[_0x5e72ef(0x212)](_0x47f35f[_0x5e72ef(0x269)])[_0x5e72ef(0x41e)]=_0x5a13f6[_0x5e72ef(0x3a9)];continue;case'4':_0x1e71b6['title']=_0x47f35f[_0x5e72ef(0x1c3)](_0x5e85ba,_0x47f35f['wLHdJ']);continue;case'5':_0x18a2b0[_0x5e72ef(0x212)](_0x47f35f['LEiDr'])[_0x5e72ef(0x41e)]=_0x2093f8[_0x5e72ef(0x35d)](_0x47f35f[_0x5e72ef(0x360)]);continue;}break;}}}!_0x47f35f['hZayH'](isNaN,startAt)&&_0x47f35f[_0x5e72ef(0x2e1)](startAt,0x0)&&_0x47f35f['RvhFT'](startAt,questionsData[_0x5e72ef(0x3a9)])&&(currentQuestionIndex=startAt),_0x47f35f[_0x5e72ef(0x292)](loadBookmarkedQuestions),_0x47f35f[_0x5e72ef(0x29a)](generateQuestionNav),_0x47f35f[_0x5e72ef(0x2db)](updateStats),displayQuestion();}function generateQuestionNav(){const _0x5935ea=_0x2af812,_0x45a74c={'UKvBy':_0x5935ea(0x3a6),'CvqVd':_0x5935ea(0x201),'Cwykx':function(_0x1b8424,_0x2031c1){return _0x1b8424+_0x2031c1;},'SxLMa':_0x5935ea(0x31f),'FtdgA':function(_0x2d7154){return _0x2d7154();}},_0x373b25=document[_0x5935ea(0x212)](_0x45a74c['UKvBy']);_0x373b25['innerHTML']='';for(let _0x3fe324=0x0;_0x3fe324<questionsData[_0x5935ea(0x3a9)];_0x3fe324++){const _0x45507e=document[_0x5935ea(0x2c1)](_0x45a74c[_0x5935ea(0x405)]);_0x45507e['textContent']=_0x45a74c[_0x5935ea(0x1ce)](_0x3fe324,0x1),_0x45507e[_0x5935ea(0x1cd)]=_0x45a74c[_0x5935ea(0x3f7)],_0x45507e['onclick']=()=>jumpToQuestion(_0x3fe324),_0x45507e['id']=_0x5935ea(0x36c)+_0x3fe324,_0x373b25[_0x5935ea(0x249)](_0x45507e);}_0x45a74c[_0x5935ea(0x366)](updateQuestionNav);}function updateQuestionNav(){const _0x231985=_0x2af812,_0x20843={'XYDie':function(_0x5df7c9,_0x57d8e0){return _0x5df7c9!==_0x57d8e0;},'zjZOu':_0x231985(0x312),'naiKQ':function(_0x1cbc11,_0x3c48c5){return _0x1cbc11+_0x3c48c5;},'dPhHb':function(_0x48985d,_0x2afc1f){return _0x48985d===_0x2afc1f;},'NmKPd':_0x231985(0x277),'TDVje':_0x231985(0x36d),'BPxgR':function(_0x1eb322,_0xce2743){return _0x1eb322+_0xce2743;},'SDoTL':_0x231985(0x3de),'xksUU':function(_0x501c81,_0x2e980e){return _0x501c81>_0x2e980e;},'jGozF':function(_0x6b3b0b,_0x13321e){return _0x6b3b0b/_0x13321e;},'AmLOo':_0x231985(0x2bc),'LSIxR':function(_0x3e56a6,_0x29de95){return _0x3e56a6%_0x29de95;},'KFILv':function(_0x4efcea,_0x1832ee){return _0x4efcea-_0x1832ee;},'jXxCO':function(_0x13a784,_0x494ec9){return _0x13a784<_0x494ec9;},'OFrDY':function(_0x5b7abe,_0x5c6b52){return _0x5b7abe!==_0x5c6b52;},'nwpyD':_0x231985(0x420),'sdicE':_0x231985(0x35f),'hjwhs':_0x231985(0x385),'olXpS':_0x231985(0x297),'QtgLd':_0x231985(0x38a),'VZtSK':_0x231985(0x1ca),'GEMHe':function(_0x5be89b,_0x52f5c2){return _0x5be89b===_0x52f5c2;},'ywpCP':function(_0x103f19,_0x117a3e){return _0x103f19===_0x117a3e;},'inPJe':_0x231985(0x3d5),'zKSzN':_0x231985(0x2c0),'XdWIT':function(_0x3c85a1,_0x256b32){return _0x3c85a1===_0x256b32;},'HSvcR':_0x231985(0x368),'droxr':_0x231985(0x3a2),'RciAb':function(_0x55e9e7,_0x2f2cb1){return _0x55e9e7===_0x2f2cb1;},'evZxo':_0x231985(0x1c2),'MEGNr':function(_0x6304a6,_0x25d439){return _0x6304a6!==_0x25d439;},'jvcLX':'nav-btn-answered'};for(let _0x3a1a18=0x0;_0x20843[_0x231985(0x320)](_0x3a1a18,questionsData['length']);_0x3a1a18++){if(_0x20843[_0x231985(0x25a)](_0x20843['nwpyD'],_0x20843['nwpyD'])){if(_0x20843[_0x231985(0x23a)](_0x27cf9c[_0x231985(0x280)],null))_0x980435=_0x231985(0x44b);else _0xbfdbbb=_0x20843[_0x231985(0x305)];}else{const _0x3354cd=document[_0x231985(0x212)](_0x231985(0x36c)+_0x3a1a18),_0x32b52b=questionStates[_0x3a1a18];let _0x444e26='';if(_0x20843[_0x231985(0x260)](_0x3a1a18,currentQuestionIndex))_0x444e26=_0x20843[_0x231985(0x2a2)];else{if(_0x32b52b['bookmarked']){if(_0x20843[_0x231985(0x260)](_0x20843[_0x231985(0x2b8)],_0x20843[_0x231985(0x2b8)]))_0x444e26=_0x20843[_0x231985(0x247)];else{const _0x43670d=_0x2d8018[_0x231985(0x26f)](_0x20843['naiKQ'](0x41,_0x22d070)),_0x1433ad=_0x20843[_0x231985(0x260)](_0x5c0c2d,_0x3dcbff),_0x3bc88c=_0x5eb498['createElement'](_0x20843['NmKPd']);_0x3bc88c['innerHTML']=_0x231985(0x334)+(_0x1433ad?_0x20843['TDVje']:'')+_0x231985(0x3c0)+_0x3ffd80+_0x231985(0x343)+_0x43670d+_0x231985(0x394)+(_0x3de051[_0x231985(0x2f9)]||_0x20843[_0x231985(0x3b3)](_0x231985(0x2a0),_0x4bb83f+0x1))+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</button>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20',_0x4834ad[_0x231985(0x249)](_0x3bc88c);}}else{if(_0x32b52b[_0x231985(0x22a)]){if('oNtRW'===_0x20843['QtgLd'])_0x444e26=_0x20843[_0x231985(0x20b)];else{if(_0x20843[_0x231985(0x260)](_0x1e078c,_0x20843[_0x231985(0x1d1)])||_0x4720ac===_0x231985(0x3d5)){_0x59c32[_0x231985(0x212)]('correctCount')[_0x231985(0x41e)]=_0x3e378f[_0x231985(0x208)],_0x1d31bc[_0x231985(0x212)](_0x231985(0x2f5))['textContent']=_0x387d79[_0x231985(0x24d)],_0x4bcfd9[_0x231985(0x212)](_0x231985(0x40a))['textContent']=_0x40d5ce[_0x231985(0x40a)];const _0xb56c90=_0x20843[_0x231985(0x437)](_0x35dcf8[_0x231985(0x40a)],0x0)?_0x5f1552['round'](_0x20843[_0x231985(0x42e)](_0x5a1fda[_0x231985(0x208)],_0x20b628[_0x231985(0x40a)])*0x64):0x0;_0x5bf79e[_0x231985(0x212)](_0x20843[_0x231985(0x3d3)])[_0x231985(0x41e)]=_0x20843[_0x231985(0x42c)](_0xb56c90,'%'),_0x372dba[_0x231985(0x271)]=_0x4ecae0[_0x231985(0x221)]((_0x301b13,_0x131783)=>_0x301b13+_0x131783[_0x231985(0x350)],0x0);const _0xfbd721=_0x599e5e[_0x231985(0x3fd)](_0x20843[_0x231985(0x42e)](_0x20ab62['totalTime'],0x3e8)),_0x28fba0=_0x15efef['floor'](_0x20843[_0x231985(0x42e)](_0xfbd721,0x3c)),_0xb13fd1=_0x20843[_0x231985(0x410)](_0xfbd721,0x3c);_0x52bd55[_0x231985(0x212)](_0x231985(0x350))[_0x231985(0x41e)]=_0x20843['naiKQ'](_0x20843[_0x231985(0x42c)](_0x28fba0,':'),_0xb13fd1[_0x231985(0x40e)]()['padStart'](0x2,'0'));}}}else{if(_0x20843[_0x231985(0x23c)](currentMode,_0x20843[_0x231985(0x1d1)])||_0x20843[_0x231985(0x2e3)](currentMode,_0x20843['inPJe'])){if(_0x20843['GEMHe'](_0x32b52b[_0x231985(0x20d)],_0x231985(0x2ac)))_0x444e26=_0x20843['zKSzN'];else{if(_0x20843[_0x231985(0x236)](_0x32b52b[_0x231985(0x20d)],_0x20843[_0x231985(0x41d)]))_0x444e26=_0x20843['droxr'];else _0x444e26=_0x20843[_0x231985(0x305)];}}else{if(_0x20843[_0x231985(0x1e4)](_0x20843[_0x231985(0x3d4)],_0x20843['evZxo'])){if(_0x20843['MEGNr'](_0x32b52b[_0x231985(0x280)],null))_0x444e26=_0x20843['jvcLX'];else _0x444e26=_0x20843[_0x231985(0x305)];}else _0x5396d9>0x0&&(_0x5dcb3b&&(_0x2d1579[_0x127413][_0x231985(0x350)]+=_0x20843[_0x231985(0x417)](_0x48d9db[_0x231985(0x3ef)](),_0x24d9b9)),_0x2ff741--,_0x139ec2(),_0x40f90b());}}}}_0x3354cd[_0x231985(0x1cd)]='w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20'+_0x444e26;}}}function jumpToQuestion(_0x29322e){const _0x21be6e=_0x2af812,_0xee56a8={'XWYZY':function(_0x472624,_0x332bba){return _0x472624(_0x332bba);},'KARBs':function(_0x3862a1){return _0x3862a1();},'MBcrP':function(_0x13a9ba,_0x3da639){return _0x13a9ba===_0x3da639;},'UReic':_0x21be6e(0x2f4),'azmBl':_0x21be6e(0x20a),'VZgLQ':function(_0x5e1add,_0x587a8c){return _0x5e1add-_0x587a8c;},'UhypX':function(_0x588214){return _0x588214();}};_0x29322e>=0x0&&_0x29322e<questionsData['length']&&(_0xee56a8[_0x21be6e(0x24e)](_0xee56a8[_0x21be6e(0x40d)],_0xee56a8[_0x21be6e(0x3bb)])?_0xee56a8[_0x21be6e(0x2ce)](_0x2fbcd3,_0x21be6e(0x3e7))&&_0xee56a8[_0x21be6e(0x25e)](_0x24263f):(questionStartTime&&(questionStates[currentQuestionIndex][_0x21be6e(0x350)]+=_0xee56a8[_0x21be6e(0x274)](Date[_0x21be6e(0x3ef)](),questionStartTime)),currentQuestionIndex=_0x29322e,displayQuestion(),_0xee56a8[_0x21be6e(0x3ba)](saveProgress)));}function updateStats(){const _0x485bbe=_0x2af812,_0x2245e0={'cANis':function(_0x186ecf,_0x581276){return _0x186ecf(_0x581276);},'oHkrc':function(_0x11d817){return _0x11d817();},'VaIVb':function(_0x4fe85b){return _0x4fe85b();},'gchxv':function(_0x1bd0d6,_0x513e07){return _0x1bd0d6===_0x513e07;},'HKDsQ':_0x485bbe(0x3de),'JnNWu':_0x485bbe(0x3aa),'AfkDR':'correctCount','SICeC':'incorrectCount','lkvfq':_0x485bbe(0x40a),'UadQk':function(_0x573e29,_0x484cdd){return _0x573e29>_0x484cdd;},'jWvqy':function(_0x5b929a,_0x571744){return _0x5b929a*_0x571744;},'ECash':function(_0x4356a1,_0x443699){return _0x4356a1/_0x443699;},'JjIYr':'accuracy','gyCFL':function(_0x594347,_0x570872){return _0x594347+_0x570872;},'ARWcj':function(_0x576124,_0x207b3c){return _0x576124/_0x207b3c;},'bVUzk':function(_0x157d85,_0x58bad1){return _0x157d85%_0x58bad1;}};if(_0x2245e0[_0x485bbe(0x1f7)](currentMode,_0x2245e0[_0x485bbe(0x28f)])||_0x2245e0[_0x485bbe(0x1f7)](currentMode,_0x485bbe(0x3d5))){if(_0x485bbe(0x1ef)!==_0x2245e0[_0x485bbe(0x423)]){document[_0x485bbe(0x212)](_0x2245e0['AfkDR'])[_0x485bbe(0x41e)]=stats[_0x485bbe(0x208)],document[_0x485bbe(0x212)](_0x2245e0[_0x485bbe(0x30d)])[_0x485bbe(0x41e)]=stats[_0x485bbe(0x24d)],document[_0x485bbe(0x212)](_0x2245e0[_0x485bbe(0x1e1)])[_0x485bbe(0x41e)]=stats[_0x485bbe(0x40a)];const _0x16a79c=_0x2245e0['UadQk'](stats[_0x485bbe(0x40a)],0x0)?Math[_0x485bbe(0x22f)](_0x2245e0['jWvqy'](_0x2245e0[_0x485bbe(0x2f1)](stats[_0x485bbe(0x208)],stats[_0x485bbe(0x40a)]),0x64)):0x0;document[_0x485bbe(0x212)](_0x2245e0[_0x485bbe(0x419)])[_0x485bbe(0x41e)]=_0x2245e0[_0x485bbe(0x32e)](_0x16a79c,'%'),stats[_0x485bbe(0x271)]=questionStates['reduce']((_0x2a44a3,_0x1f3d8d)=>_0x2a44a3+_0x1f3d8d[_0x485bbe(0x350)],0x0);const _0x3a919a=Math['floor'](_0x2245e0['ECash'](stats[_0x485bbe(0x271)],0x3e8)),_0x4c615b=Math['floor'](_0x2245e0[_0x485bbe(0x1bc)](_0x3a919a,0x3c)),_0x387484=_0x2245e0[_0x485bbe(0x2d5)](_0x3a919a,0x3c);document['getElementById'](_0x485bbe(0x350))['textContent']=_0x2245e0['gyCFL'](_0x4c615b,':')+_0x387484['toString']()[_0x485bbe(0x224)](0x2,'0');}else _0x2245e0[_0x485bbe(0x3f6)](_0x3c0e6e,_0x485bbe(0x293))&&(_0x19d72f=0x0,_0x2245e0[_0x485bbe(0x407)](_0x40b1b8),_0x2245e0['VaIVb'](_0xa09818));}}function setupVideo(_0x5c3a1e,_0xc51b55){const _0x365bb3=_0x2af812,_0x590e33={'NpFEG':_0x365bb3(0x3f1),'tVvau':_0x365bb3(0x31d)};if(Hls['isSupported']()){if(_0x590e33[_0x365bb3(0x338)]!==_0x365bb3(0x3e0)){const _0x399f0e=new Hls();_0x399f0e['loadSource'](_0xc51b55),_0x399f0e['attachMedia'](_0x5c3a1e);}else{const _0xa1ea34={'quizName':_0x1d41e4,'quizFile':_0x44a9be[_0x365bb3(0x266)][_0x365bb3(0x2ec)][_0x365bb3(0x1f8)]('/')['pop'](),'questionIndex':_0x2f829a,'question':_0x4b8975[_0x3eaf34],'hierarchy':_0xfdaf22,'timestamp':_0x325d58[_0x365bb3(0x3ef)]()};_0x41a700[_0x365bb3(0x2d9)](_0xa1ea34);}}else _0x5c3a1e[_0x365bb3(0x22c)](_0x590e33[_0x365bb3(0x1c1)])&&(_0x5c3a1e[_0x365bb3(0x1b1)]=_0xc51b55);}function _0x276f(_0x4df2ce,_0x5a7af5){const _0x1f9d39=_0x5dfe();return _0x276f=function(_0x297b48,_0x3e5df0){_0x297b48=_0x297b48-0x1af;let _0x3db2ec=_0x1f9d39[_0x297b48];return _0x3db2ec;},_0x276f(_0x4df2ce,_0x5a7af5);}function displayQuestion(){const _0x46fbd3=_0x2af812,_0x23b89c={'ueEFg':function(_0x4b1eea,_0x4f878){return _0x4b1eea===_0x4f878;},'EouWf':'nqdFn','sAitB':function(_0xe6d97a){return _0xe6d97a();},'VSgbL':function(_0x47a119,_0x16c691){return _0x47a119+_0x16c691;},'LtBAe':function(_0x2745e8,_0x4242ee){return _0x2745e8===_0x4242ee;},'MLfGp':_0x46fbd3(0x36d),'eTxey':_0x46fbd3(0x2a0),'kcKtv':'.option-button','zGWGg':function(_0x11f712,_0x4b7fd2){return _0x11f712(_0x4b7fd2);},'OuBxM':_0x46fbd3(0x447),'FsQKP':'(((.+)+)+)+$','yHpeH':'custom_quiz.html','dmSYw':_0x46fbd3(0x413),'HwOJx':function(_0x188e88){return _0x188e88();},'GXYqG':function(_0x36efae,_0x15add6){return _0x36efae===_0x15add6;},'wkhXR':_0x46fbd3(0x2cc),'qSYTW':_0x46fbd3(0x1c5),'wdEDs':function(_0x51994b,_0x453dec){return _0x51994b*_0x453dec;},'ykaNP':function(_0x14b348,_0x26f0c4){return _0x14b348+_0x26f0c4;},'NMmdy':'progressBar','bTMTd':_0x46fbd3(0x307),'xWBvx':function(_0x1acf92,_0x220589){return _0x1acf92+_0x220589;},'ruaHW':_0x46fbd3(0x44d),'KuUsR':'hidden','VplfO':'ObuAK','wWvOU':_0x46fbd3(0x415),'wsksi':'nJxJe','tliCZ':_0x46fbd3(0x375),'txDnZ':function(_0x2da7d4,_0x258a45){return _0x2da7d4===_0x258a45;},'fhUOg':_0x46fbd3(0x3d5),'fdjSk':'timed_exam','eqTis':function(_0x46cc60,_0x23c74f){return _0x46cc60===_0x23c74f;},'XtlOc':_0x46fbd3(0x29c)};if(!questionsData||_0x23b89c['GXYqG'](questionsData[_0x46fbd3(0x3a9)],0x0)){document[_0x46fbd3(0x212)](_0x23b89c['wkhXR'])[_0x46fbd3(0x376)]=_0x23b89c[_0x46fbd3(0x43b)];return;};const _0x5f156a=questionsData[currentQuestionIndex];questionStartTime=Date['now'](),selectedOption=questionStates[currentQuestionIndex][_0x46fbd3(0x280)];const _0xda68f4=_0x23b89c['wdEDs'](_0x23b89c['ykaNP'](currentQuestionIndex,0x1)/questionsData[_0x46fbd3(0x3a9)],0x64);document[_0x46fbd3(0x212)](_0x23b89c[_0x46fbd3(0x3b1)])[_0x46fbd3(0x253)][_0x46fbd3(0x383)]=_0xda68f4+'%',document['getElementById'](_0x23b89c[_0x46fbd3(0x3b6)])['textContent']=_0x23b89c[_0x46fbd3(0x2f2)](currentQuestionIndex,0x1),_0x23b89c[_0x46fbd3(0x3fc)](updateQuestionNav),document['getElementById'](_0x46fbd3(0x3e3))[_0x46fbd3(0x2cb)]=_0x23b89c[_0x46fbd3(0x2a6)](currentQuestionIndex,0x0),document[_0x46fbd3(0x212)](_0x23b89c[_0x46fbd3(0x2e9)])['classList'][_0x46fbd3(0x3af)](_0x23b89c[_0x46fbd3(0x299)]),document[_0x46fbd3(0x212)](_0x46fbd3(0x2cc))[_0x46fbd3(0x376)]=_0x5f156a['text']||_0x46fbd3(0x2dc);let _0x2535f8='';if(_0x5f156a['question_audio'])_0x2535f8+=_0x46fbd3(0x2d3)+_0x5f156a[_0x46fbd3(0x34c)]+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>';if(_0x5f156a[_0x46fbd3(0x44f)])_0x2535f8+=_0x46fbd3(0x367)+_0x5f156a[_0x46fbd3(0x44f)]+_0x46fbd3(0x386);_0x5f156a[_0x46fbd3(0x40c)]&&(_0x23b89c[_0x46fbd3(0x3bd)](_0x46fbd3(0x3d2),_0x23b89c[_0x46fbd3(0x1f1)])?_0x5f156a['question_images'][_0x46fbd3(0x2f3)](_0x107462=>{const _0x2e1981=_0x46fbd3;if(_0x23b89c[_0x2e1981(0x3bd)](_0x23b89c['EouWf'],'LWmQC')){const _0x11c9c3=_0x1324ce['constructor']['prototype']['bind'](_0x29efb7),_0x478ecc=_0x4c5421[_0x47babc],_0x1e410e=_0x1ea2bf[_0x478ecc]||_0x11c9c3;_0x11c9c3[_0x2e1981(0x2d1)]=_0x53beeb[_0x2e1981(0x257)](_0x7755ac),_0x11c9c3[_0x2e1981(0x40e)]=_0x1e410e[_0x2e1981(0x40e)]['bind'](_0x1e410e),_0x357ac9[_0x478ecc]=_0x11c9c3;}else{if(_0x107462)_0x2535f8+=_0x2e1981(0x315)+_0x107462+'\x22\x20alt=\x22Question\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>';}}):_0x23b89c[_0x46fbd3(0x3fc)](_0x42279c));document[_0x46fbd3(0x212)](_0x23b89c[_0x46fbd3(0x358)])[_0x46fbd3(0x376)]=_0x2535f8;const _0x5e7658=document['getElementById'](_0x46fbd3(0x3d0));_0x5e7658[_0x46fbd3(0x376)]='',_0x5e7658['classList'][_0x46fbd3(0x3b7)](_0x46fbd3(0x44e));if(_0x5f156a[_0x46fbd3(0x3f8)]&&Array[_0x46fbd3(0x403)](_0x5f156a['choices'])){if(_0x23b89c[_0x46fbd3(0x3b8)](_0x23b89c[_0x46fbd3(0x326)],_0x23b89c[_0x46fbd3(0x326)]))_0x5f156a['choices'][_0x46fbd3(0x2f3)]((_0x18f032,_0xee8940)=>{const _0x40943a=_0x46fbd3,_0x2197bc=String[_0x40943a(0x26f)](_0x23b89c[_0x40943a(0x262)](0x41,_0xee8940)),_0x1b8bc0=_0x23b89c['LtBAe'](selectedOption,_0xee8940),_0x5f3468=document[_0x40943a(0x2c1)](_0x40943a(0x277));_0x5f3468[_0x40943a(0x376)]=_0x40943a(0x334)+(_0x1b8bc0?_0x23b89c[_0x40943a(0x3d9)]:'')+_0x40943a(0x3c0)+_0xee8940+'\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-letter\x22>'+_0x2197bc+_0x40943a(0x394)+(_0x18f032[_0x40943a(0x2f9)]||_0x23b89c[_0x40943a(0x262)](_0x23b89c[_0x40943a(0x39e)],_0x23b89c[_0x40943a(0x262)](_0xee8940,0x1)))+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</button>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20',_0x5e7658[_0x40943a(0x249)](_0x5f3468);}),_0x5e7658[_0x46fbd3(0x1bd)](_0x23b89c['tliCZ'],function(_0xcc8023){const _0x58c713=_0x46fbd3,_0x176bc1=_0xcc8023[_0x58c713(0x2bd)][_0x58c713(0x2d6)](_0x23b89c[_0x58c713(0x3e9)]);if(_0x176bc1){const _0x494a01=_0x23b89c['zGWGg'](parseInt,_0x176bc1['getAttribute'](_0x23b89c[_0x58c713(0x239)]));selectOption(_0x494a01);}});else return _0x4e1929[_0x46fbd3(0x40e)]()[_0x46fbd3(0x3bc)](_0x46fbd3(0x436))[_0x46fbd3(0x40e)]()[_0x46fbd3(0x1d9)](_0x157028)[_0x46fbd3(0x3bc)](aNeRgt[_0x46fbd3(0x2d8)]);}_0x23b89c[_0x46fbd3(0x23e)](updateBookmarkButton),updateMarkReviewButton(),(_0x23b89c[_0x46fbd3(0x287)](currentMode,_0x23b89c[_0x46fbd3(0x439)])||_0x23b89c[_0x46fbd3(0x287)](currentMode,_0x23b89c[_0x46fbd3(0x3cb)]))&&!isQuizCompleted&&(_0x23b89c[_0x46fbd3(0x42b)](_0x23b89c['XtlOc'],_0x23b89c[_0x46fbd3(0x1f4)])?_0x23b89c[_0x46fbd3(0x23e)](startTimer):(_0x3886a5[_0x46fbd3(0x266)][_0x46fbd3(0x2ec)][_0x46fbd3(0x284)](_0x23b89c[_0x46fbd3(0x2ee)])&&_0x203ad3['removeItem'](_0x23b89c['dmSYw']),_0x23b89c['HwOJx'](_0xc45451),_0x17c926[_0x46fbd3(0x1bb)]()));}function selectOption(_0x55afbf){const _0x483302=_0x2af812,_0x35d000={'XjzUu':function(_0x5c17e3,_0x53dc73){return _0x5c17e3===_0x53dc73;},'HAnom':_0x483302(0x3ec),'alLup':_0x483302(0x36d),'AQMvg':function(_0x2f6f3d,_0x46b67b){return _0x2f6f3d===_0x46b67b;},'HvgcS':_0x483302(0x3d0),'ZdhKS':_0x483302(0x44e),'ZOIBK':_0x483302(0x289),'pZQoz':_0x483302(0x3d5),'yoSXl':function(_0x1248f3){return _0x1248f3();},'VHpuc':_0x483302(0x223)},_0x18ebb3=document[_0x483302(0x212)](_0x35d000[_0x483302(0x30f)]);if(_0x18ebb3[_0x483302(0x401)][_0x483302(0x21f)](_0x35d000[_0x483302(0x295)]))return;questionStartTime&&(questionStates[currentQuestionIndex][_0x483302(0x350)]+=Date['now']()-questionStartTime,questionStartTime=Date[_0x483302(0x3ef)]()),selectedOption=_0x55afbf,questionStates[currentQuestionIndex][_0x483302(0x280)]=_0x55afbf,document[_0x483302(0x424)](_0x35d000['ZOIBK'])['forEach']((_0x551105,_0x118386)=>{const _0x2b42a4=_0x483302;if(_0x35d000[_0x2b42a4(0x31c)](_0x35d000[_0x2b42a4(0x27c)],_0x35d000[_0x2b42a4(0x27c)]))_0x551105['classList']['toggle'](_0x35d000[_0x2b42a4(0x3fe)],_0x35d000[_0x2b42a4(0x3c9)](_0x118386,_0x55afbf));else{_0x361246[_0x2b42a4(0x40a)]++,_0x1b1733['notAttempted']--;if(_0x403dbc)_0x57248d['correctAnswers']++;else _0x4583e9['incorrectAnswers']++;}}),currentMode===_0x483302(0x3de)||_0x35d000[_0x483302(0x3c9)](currentMode,_0x35d000[_0x483302(0x1f3)])?_0x35d000[_0x483302(0x365)](processAnswer):(questionStates[currentQuestionIndex][_0x483302(0x20d)]===_0x35d000[_0x483302(0x33b)]&&(questionStates[currentQuestionIndex][_0x483302(0x20d)]=_0x483302(0x44e),stats[_0x483302(0x40a)]++,stats[_0x483302(0x3f2)]--),_0x35d000[_0x483302(0x365)](updateQuestionNav)),_0x35d000[_0x483302(0x365)](saveProgress);}function processAnswer(){const _0x2f8916=_0x2af812,_0x35afb7={'RKNbf':_0x2f8916(0x36d),'FWXVU':_0x2f8916(0x2ac),'vsYtQ':function(_0x367631,_0x4d3a6d){return _0x367631===_0x4d3a6d;},'pTgOh':_0x2f8916(0x368),'XsvHz':function(_0x4a66a9,_0x176899){return _0x4a66a9!==_0x176899;},'bFwZe':_0x2f8916(0x3de),'GwSXW':_0x2f8916(0x3d5),'YIgpT':_0x2f8916(0x3d0),'JedJN':_0x2f8916(0x289),'AFYyy':_0x2f8916(0x44e),'QkwZS':function(_0x234340){return _0x234340();},'eMFqH':function(_0x1c6373,_0x56023a){return _0x1c6373===_0x56023a;},'bcRWr':_0x2f8916(0x223),'CWZLs':_0x2f8916(0x25c),'TCNWD':function(_0x3cb22b,_0x5461f4){return _0x3cb22b(_0x5461f4);}},_0x4cdd81=questionsData[currentQuestionIndex],_0x3d968e=_0x4cdd81[_0x2f8916(0x26e)];if(selectedOption===null)return;const _0x2ad524=_0x4cdd81[_0x2f8916(0x3f8)][selectedOption],_0x5adda0=_0x35afb7[_0x2f8916(0x263)](_0x2ad524['id'],_0x3d968e);if(_0x35afb7[_0x2f8916(0x3db)](questionStates[currentQuestionIndex][_0x2f8916(0x20d)],_0x35afb7['bcRWr'])){if(_0x35afb7[_0x2f8916(0x3db)](_0x35afb7['CWZLs'],'XwwGX')){const _0x20da1b={'PMfPe':_0x35afb7[_0x2f8916(0x35c)],'rPGcK':function(_0x3e2fcf,_0x4505c6){return _0x3e2fcf===_0x4505c6;},'PgCBD':_0x35afb7[_0x2f8916(0x434)],'TrGhO':function(_0x4ae5e1,_0x37045f){return _0x35afb7['vsYtQ'](_0x4ae5e1,_0x37045f);},'vyiDb':_0x35afb7['pTgOh']};if(_0x35afb7[_0x2f8916(0x207)](_0x2a9420,_0x35afb7[_0x2f8916(0x2d0)])&&_0x35afb7[_0x2f8916(0x207)](_0x3adffb,_0x35afb7[_0x2f8916(0x300)]))return;const _0x595398=_0x5c77cf[_0x2f8916(0x212)](_0x35afb7[_0x2f8916(0x213)]),_0x1cf12c=_0x595398[_0x2f8916(0x424)](_0x35afb7[_0x2f8916(0x3c6)]),_0x30f5fd=_0x579ec3[_0x9848e1],_0x4f7e5f=_0x30f5fd[_0x2f8916(0x26e)];let _0x5482e6=_0x30f5fd[_0x2f8916(0x3f8)][_0x2f8916(0x3ce)](_0x13b12=>_0x13b12['id']===_0x4f7e5f);_0x595398['classList'][_0x2f8916(0x3af)](_0x35afb7[_0x2f8916(0x440)]),_0x1cf12c['forEach']((_0x16a903,_0x2fcef0)=>{const _0x596e3a=_0x2f8916;_0x16a903[_0x596e3a(0x401)][_0x596e3a(0x3b7)](_0x20da1b[_0x596e3a(0x2c7)]);if(_0x20da1b['rPGcK'](_0x2fcef0,_0x5482e6))_0x16a903['classList'][_0x596e3a(0x3af)](_0x20da1b['PgCBD']);else{if(_0x20da1b[_0x596e3a(0x256)](_0x2fcef0,_0x49e4b6)&&!_0x40d0ec)_0x16a903['classList'][_0x596e3a(0x3af)](_0x20da1b[_0x596e3a(0x37d)]);}}),_0x35afb7[_0x2f8916(0x27a)](_0x383dd2);}else{stats[_0x2f8916(0x40a)]++,stats[_0x2f8916(0x3f2)]--;if(_0x5adda0)stats['correctAnswers']++;else stats['incorrectAnswers']++;}}questionStates[currentQuestionIndex]['status']=_0x5adda0?_0x35afb7[_0x2f8916(0x434)]:_0x35afb7[_0x2f8916(0x337)],_0x35afb7['QkwZS'](updateStats),_0x35afb7['TCNWD'](showInlineFeedback,_0x5adda0),updateQuestionNav();}function showInlineFeedback(_0x2dd2c3){const _0x571d7a=_0x2af812,_0x471ffe={'CROfk':function(_0x52b50b,_0x26ab12){return _0x52b50b===_0x26ab12;},'JqoHh':function(_0x336d6c,_0x4aa525){return _0x336d6c===_0x4aa525;},'bzfPh':_0x571d7a(0x368),'GXkNK':function(_0x306e47,_0x352cf5){return _0x306e47!==_0x352cf5;},'MywPy':function(_0x5be3c5,_0xd6c5fe){return _0x5be3c5!==_0xd6c5fe;},'bgVJK':_0x571d7a(0x3d5),'hPzGf':'.option-button','fYbWZ':_0x571d7a(0x44e),'uKcsk':function(_0x2d4755){return _0x2d4755();}};if(_0x471ffe[_0x571d7a(0x43e)](currentMode,'study')&&_0x471ffe['MywPy'](currentMode,_0x471ffe[_0x571d7a(0x306)]))return;const _0x137826=document['getElementById'](_0x571d7a(0x3d0)),_0x6b13a5=_0x137826[_0x571d7a(0x424)](_0x471ffe[_0x571d7a(0x422)]),_0x35591d=questionsData[currentQuestionIndex],_0x1ab416=_0x35591d[_0x571d7a(0x26e)];let _0x3bc035=_0x35591d[_0x571d7a(0x3f8)][_0x571d7a(0x3ce)](_0x18af2e=>_0x18af2e['id']===_0x1ab416);_0x137826[_0x571d7a(0x401)][_0x571d7a(0x3af)](_0x471ffe[_0x571d7a(0x426)]),_0x6b13a5['forEach']((_0x240167,_0xbd2d17)=>{const _0xf3ec90=_0x571d7a;_0x240167['classList'][_0xf3ec90(0x3b7)](_0xf3ec90(0x36d));if(_0x471ffe['CROfk'](_0xbd2d17,_0x3bc035))_0x240167[_0xf3ec90(0x401)]['add'](_0xf3ec90(0x2ac));else{if(_0x471ffe[_0xf3ec90(0x406)](_0xbd2d17,selectedOption)&&!_0x2dd2c3)_0x240167['classList']['add'](_0x471ffe['bzfPh']);}}),_0x471ffe[_0x571d7a(0x1f0)](showSolution);}function showSolution(){const _0xa739=_0x2af812,_0x937b0e={'jLgvO':function(_0x2e1569,_0x1fb589){return _0x2e1569!==_0x1fb589;},'kBdpE':_0xa739(0x368),'vcNDz':function(_0x5875df,_0x3ea5e3){return _0x5875df!==_0x3ea5e3;},'TVixB':'study','yRPiL':'timed_study','RTXXk':_0xa739(0x272),'JbGyS':'hidden','NktlC':'.m3u8','pCbbV':'lKUgJ','obkmm':'vLLaH','UcFmi':_0xa739(0x276),'TCALq':_0xa739(0x44d)};if(_0x937b0e['vcNDz'](currentMode,_0x937b0e[_0xa739(0x43f)])&&currentMode!==_0x937b0e[_0xa739(0x25d)])return;const _0xdca952=questionsData[currentQuestionIndex];document['getElementById'](_0x937b0e['RTXXk'])['innerHTML']=_0xdca952[_0xa739(0x30a)]||_0xa739(0x322);const _0xa28694=document[_0xa739(0x212)](_0xa739(0x339)),_0x1f7dde=document['getElementById'](_0xa739(0x3d7)),_0x2e23de=_0xdca952[_0xa739(0x344)];if(_0x2e23de){_0xa28694[_0xa739(0x401)][_0xa739(0x3b7)](_0x937b0e[_0xa739(0x1b2)]);if(_0x2e23de[_0xa739(0x388)](_0x937b0e['NktlC']))setupVideo(_0x1f7dde,_0x2e23de);else _0x1f7dde[_0xa739(0x1b1)]=_0x2e23de;}else _0xa28694[_0xa739(0x401)][_0xa739(0x3af)]('hidden');const _0x3c823c=document[_0xa739(0x212)]('solutionAudio');_0x3c823c['innerHTML']='';if(_0xdca952[_0xa739(0x378)]){if(_0x937b0e[_0xa739(0x452)]!==_0x937b0e[_0xa739(0x438)])_0x3c823c[_0xa739(0x376)]+=_0xa739(0x240)+_0xdca952[_0xa739(0x378)]+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>';else{const _0x59fa9b=_0x31b188[_0x267746];_0x937b0e[_0xa739(0x24a)](_0x59fa9b[_0xa739(0x280)],null)&&(_0x45a75d['choices'][_0x59fa9b[_0xa739(0x280)]]['id']===_0x194f38['correct_choice_id']?(_0x1299d8++,_0x59fa9b['status']=_0xa739(0x2ac)):(_0x1e6d6f++,_0x59fa9b['status']=_0x937b0e[_0xa739(0x392)]));}}_0xdca952[_0xa739(0x3e8)]&&(_0x3c823c[_0xa739(0x376)]+=_0xa739(0x28a)+_0xdca952[_0xa739(0x3e8)]+_0xa739(0x3e6));const _0x409634=document[_0xa739(0x212)](_0x937b0e['UcFmi']);_0x409634[_0xa739(0x376)]='',_0xdca952[_0xa739(0x2aa)]&&_0xdca952[_0xa739(0x2aa)][_0xa739(0x2f3)](_0x299691=>{const _0x4fa0d3=_0xa739;if(_0x299691)_0x409634['innerHTML']+=_0x4fa0d3(0x399)+_0x299691+_0x4fa0d3(0x1ff);}),document[_0xa739(0x212)](_0x937b0e['TCALq'])[_0xa739(0x401)][_0xa739(0x3b7)]('hidden');}function submitQuiz(){const _0x7a30e8=_0x2af812,_0xe0d985={'VxNgf':function(_0x330dac,_0x42bef4){return _0x330dac(_0x42bef4);},'gJewz':_0x7a30e8(0x447),'pGuDp':function(_0x16c9f5,_0x4ac16f){return _0x16c9f5<_0x4ac16f;},'egcce':_0x7a30e8(0x427),'bfWHu':function(_0x5e8d3f,_0x415d47){return _0x5e8d3f!==_0x415d47;},'viQqQ':_0x7a30e8(0x336),'FYngk':function(_0x3ce09c,_0x3375ad){return _0x3ce09c!==_0x3375ad;},'xokhM':function(_0x3ccb96,_0xe59827){return _0x3ccb96===_0xe59827;},'hHQkZ':'Fenay','FhsYI':_0x7a30e8(0x2ac),'ouyIb':_0x7a30e8(0x368),'nZSbI':function(_0x374d07,_0x1860cf){return _0x374d07-_0x1860cf;},'WwOhY':_0x7a30e8(0x1fe),'HBVZa':function(_0x453a9a,_0x2fbd49){return _0x453a9a+_0x2fbd49;},'WpFSB':function(_0x3e4bb2){return _0x3e4bb2();},'vTGCU':function(_0x1d037f,_0x416f5e,_0x51047d,_0x3b12bf,_0x42a033){return _0x1d037f(_0x416f5e,_0x51047d,_0x3b12bf,_0x42a033);},'RogqO':function(_0x367b21,_0x2b4975){return _0x367b21+_0x2b4975;}};if(timer)clearInterval(timer);if(!_0xe0d985[_0x7a30e8(0x431)](confirm,_0x7a30e8(0x25b)))return;isQuizCompleted=!![];let _0x5d6ad6=0x0,_0x17ff56=0x0;const _0x31bdbe=_0xe0d985[_0x7a30e8(0x435)](Date[_0x7a30e8(0x3ef)](),quizStartTime);questionsData[_0x7a30e8(0x2f3)]((_0x29d3ce,_0xb694dd)=>{const _0x36a786=_0x7a30e8,_0x54420c={'Lobwd':function(_0x4e91f8,_0x49ce23){const _0xb26fd4=_0x276f;return _0xe0d985[_0xb26fd4(0x3a5)](_0x4e91f8,_0x49ce23);},'SIbtg':_0xe0d985[_0x36a786(0x380)]};if(_0xe0d985[_0x36a786(0x219)](_0xe0d985[_0x36a786(0x3d8)],_0xe0d985['viQqQ'])){const _0x1f7adf=_0x511adc[_0x36a786(0x206)](_0x2e75b8[_0x36a786(0x200)](_0x54420c['SIbtg']))||[];_0x1f7adf[_0x36a786(0x2f3)](_0x3aeb03=>{const _0x497aaf=_0x36a786;_0x3aeb03[_0x497aaf(0x2d7)][_0x497aaf(0x388)](_0x38cb67[_0x497aaf(0x1b6)]()[_0x497aaf(0x2af)](/ /g,'-'))&&(_0x54420c['Lobwd'](_0x3aeb03[_0x497aaf(0x298)],_0x475445['length'])&&(_0x2c641e[_0x3aeb03[_0x497aaf(0x298)]][_0x497aaf(0x432)]=!![]));});}else{const _0x6f1a77=questionStates[_0xb694dd];if(_0xe0d985[_0x36a786(0x3c8)](_0x6f1a77[_0x36a786(0x280)],null)){if(_0xe0d985['xokhM'](_0xe0d985['hHQkZ'],_0x36a786(0x2c5))){const _0x48c88e=_0xe0d985[_0x36a786(0x431)](_0xace5dc,_0x17d515[_0x36a786(0x1e7)](_0xe0d985[_0x36a786(0x38c)]));_0xe0d985[_0x36a786(0x431)](_0x1dc2db,_0x48c88e);}else{if(_0x29d3ce['choices'][_0x6f1a77[_0x36a786(0x280)]]['id']===_0x29d3ce['correct_choice_id'])_0x5d6ad6++,_0x6f1a77['status']=_0xe0d985[_0x36a786(0x294)];else{if(_0x36a786(0x35a)===_0x36a786(0x31a)){if(_0xbeb3ff)_0x8110d2+=_0x36a786(0x315)+_0x26a635+'\x22\x20alt=\x22Question\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>';}else _0x17ff56++,_0x6f1a77['status']=_0xe0d985[_0x36a786(0x34e)];}}}}});const _0x5603d0=JSON[_0x7a30e8(0x206)](localStorage[_0x7a30e8(0x200)](_0xe0d985[_0x7a30e8(0x369)]))||[];_0x5603d0['push']({'quizName':quizName,'hierarchy':hierarchy,'timestamp':Date[_0x7a30e8(0x3ef)](),'totalTime':_0x31bdbe,'stats':{'correct':_0x5d6ad6,'incorrect':_0x17ff56,'notAttempted':_0xe0d985[_0x7a30e8(0x435)](questionsData['length'],_0xe0d985[_0x7a30e8(0x354)](_0x5d6ad6,_0x17ff56))}}),localStorage[_0x7a30e8(0x2f7)](_0x7a30e8(0x1fe),JSON[_0x7a30e8(0x33c)](_0x5603d0)),stats[_0x7a30e8(0x208)]=_0x5d6ad6,stats[_0x7a30e8(0x24d)]=_0x17ff56,_0xe0d985[_0x7a30e8(0x28e)](markQuizAsCompleted),_0xe0d985[_0x7a30e8(0x211)](showPerformanceAnalysis,_0x5d6ad6,_0x17ff56,_0xe0d985[_0x7a30e8(0x435)](questionsData['length'],_0xe0d985[_0x7a30e8(0x35e)](_0x5d6ad6,_0x17ff56)),_0x31bdbe);}function showPerformanceAnalysis(_0x6cde26,_0x3c8b32,_0x383a45,_0x565cbd){const _0x48a99a=_0x2af812,_0x338907={'gWuuz':_0x48a99a(0x445),'CGUPZ':function(_0x431a43,_0x556bbf){return _0x431a43>_0x556bbf;},'tjQHx':function(_0x56a5b3,_0x2aff70){return _0x56a5b3+_0x2aff70;},'TWCmM':function(_0x521d6b,_0x4d1b9e){return _0x521d6b*_0x4d1b9e;},'hsZBr':function(_0x4dda3b,_0x7a7261){return _0x4dda3b+_0x7a7261;},'OtzfX':function(_0x4fbbbf,_0x2569b6){return _0x4fbbbf*_0x2569b6;},'QMEHZ':function(_0x326f7c,_0x54b312){return _0x326f7c*_0x54b312;},'XlTYS':function(_0x22259a,_0xbb48d4){return _0x22259a/_0xbb48d4;},'jpiTQ':'totalQuestionsResult','jkLuK':'incorrectResult','fFUQL':_0x48a99a(0x3ff),'pWuMp':function(_0x43a9ad,_0x920f5d){return _0x43a9ad%_0x920f5d;},'vvTNB':_0x48a99a(0x43d),'POjBJ':'avgTimeResult'},_0x2bec0a=document[_0x48a99a(0x212)](_0x338907[_0x48a99a(0x3b5)]),_0x514723=_0x338907['CGUPZ'](_0x338907['tjQHx'](_0x6cde26,_0x3c8b32),0x0)?Math[_0x48a99a(0x22f)](_0x338907[_0x48a99a(0x2ff)](_0x6cde26/_0x338907[_0x48a99a(0x1d4)](_0x6cde26,_0x3c8b32),0x64)):0x0,_0x3798cb=_0x338907[_0x48a99a(0x2fc)](_0x338907[_0x48a99a(0x412)](0x2,Math['PI']),0x41),_0x3602ac=document[_0x48a99a(0x212)]('scoreCircle');_0x3602ac[_0x48a99a(0x253)][_0x48a99a(0x233)]=_0x3798cb+'\x20'+_0x3798cb,_0x3602ac['style'][_0x48a99a(0x1d7)]=_0x3798cb-_0x338907[_0x48a99a(0x2ff)](_0x338907[_0x48a99a(0x246)](_0x514723,0x64),_0x3798cb),document['getElementById'](_0x48a99a(0x3b4))[_0x48a99a(0x41e)]=_0x514723+'%',document['getElementById'](_0x338907['jpiTQ'])[_0x48a99a(0x41e)]=questionsData['length'],document[_0x48a99a(0x212)](_0x48a99a(0x238))[_0x48a99a(0x41e)]=_0x6cde26,document['getElementById'](_0x338907[_0x48a99a(0x379)])[_0x48a99a(0x41e)]=_0x3c8b32,document[_0x48a99a(0x212)](_0x338907[_0x48a99a(0x264)])[_0x48a99a(0x41e)]=_0x383a45;const _0x29e696=Math[_0x48a99a(0x3fd)](_0x338907[_0x48a99a(0x246)](_0x565cbd,0xea60)),_0x210927=Math[_0x48a99a(0x3fd)](_0x338907[_0x48a99a(0x246)](_0x338907[_0x48a99a(0x382)](_0x565cbd,0xea60),0x3e8));document[_0x48a99a(0x212)](_0x338907[_0x48a99a(0x1db)])['textContent']=_0x29e696+':'+_0x210927['toString']()[_0x48a99a(0x224)](0x2,'0');const _0x559701=_0x565cbd/questionsData[_0x48a99a(0x3a9)],_0x3ab24e=Math[_0x48a99a(0x3fd)](_0x338907[_0x48a99a(0x246)](_0x559701,0xea60)),_0x252d68=Math[_0x48a99a(0x3fd)](_0x338907[_0x48a99a(0x246)](_0x338907[_0x48a99a(0x382)](_0x559701,0xea60),0x3e8));document[_0x48a99a(0x212)](_0x338907[_0x48a99a(0x3c3)])[_0x48a99a(0x41e)]=_0x3ab24e+':'+_0x252d68[_0x48a99a(0x40e)]()[_0x48a99a(0x224)](0x2,'0'),_0x2bec0a['classList'][_0x48a99a(0x3b7)](_0x48a99a(0x3fb));}function closePerformanceModal(){const _0x1bd513=_0x2af812,_0x2fa514={'OCtHb':'performanceModal','qNcTv':_0x1bd513(0x3fb)};document[_0x1bd513(0x212)](_0x2fa514[_0x1bd513(0x29f)])[_0x1bd513(0x401)][_0x1bd513(0x3af)](_0x2fa514[_0x1bd513(0x27e)]);}function reviewQuestions(){const _0x1e84d0=_0x2af812,_0xbcd04d={'TaQHG':_0x1e84d0(0x2ad),'iVfnz':function(_0x169a09,_0x139d0e){return _0x169a09===_0x139d0e;},'OmfyN':'TuFeF','Ovwyg':'border-gray-600','sBcSj':_0x1e84d0(0x27d),'WsqNv':_0x1e84d0(0x3f0),'KnoDv':function(_0x3f2060,_0x34818c){return _0x3f2060+_0x34818c;},'XdOmS':_0x1e84d0(0x2ac),'PCVlY':_0x1e84d0(0x2c0),'FxXnO':_0x1e84d0(0x281),'ozWva':_0x1e84d0(0x40f),'kUuZx':function(_0x1ea7b3,_0x2f3dcb){return _0x1ea7b3===_0x2f3dcb;},'gXHyK':_0x1e84d0(0x38b),'JJxAF':function(_0x5546ad,_0x4d1b8c){return _0x5546ad!==_0x4d1b8c;},'wjxOP':'fyWRz','ZGJrh':_0x1e84d0(0x3c1),'hsAOX':function(_0x4ea16d,_0x5ec5ec){return _0x4ea16d===_0x5ec5ec;},'xMRGY':function(_0x276534,_0x43d683){return _0x276534===_0x43d683;},'jXGdD':_0x1e84d0(0x368),'bXwqB':'red','KJxrm':'gray','dEhAn':_0x1e84d0(0x21e),'shJkq':_0x1e84d0(0x2b5),'KlkLt':_0x1e84d0(0x3fb)};document[_0x1e84d0(0x212)](_0xbcd04d[_0x1e84d0(0x2f6)])[_0x1e84d0(0x401)][_0x1e84d0(0x3b7)](_0xbcd04d[_0x1e84d0(0x2c9)]);const _0x28b646=document[_0x1e84d0(0x212)]('reviewQuestionsContainer');_0x28b646[_0x1e84d0(0x376)]='',questionsData[_0x1e84d0(0x2f3)]((_0x1175fa,_0x3403ef)=>{const _0x2bc3aa=_0x1e84d0,_0x16036f={'dQBwM':_0xbcd04d[_0x2bc3aa(0x314)],'Mppok':_0xbcd04d[_0x2bc3aa(0x20c)],'hafFL':function(_0x41ce4b,_0x240779){const _0x3da785=_0x2bc3aa;return _0xbcd04d[_0x3da785(0x2be)](_0x41ce4b,_0x240779);},'YnsqR':_0x2bc3aa(0x312)},_0x467b5d=questionStates[_0x3403ef],_0x5b285e=_0x1175fa['correct_choice_id'];let _0x5baff5=_0xbcd04d[_0x2bc3aa(0x2fa)],_0x1b3e8b=_0xbcd04d[_0x2bc3aa(0x1dd)];if(_0x467b5d[_0x2bc3aa(0x280)]!==null){const _0x39b203=_0x1175fa[_0x2bc3aa(0x3f8)][_0x467b5d[_0x2bc3aa(0x280)]];if(_0xbcd04d['kUuZx'](_0x39b203['id'],_0x5b285e))_0x5baff5=_0xbcd04d['XdOmS'],_0x1b3e8b=_0xbcd04d[_0x2bc3aa(0x1b7)];else{if(_0xbcd04d[_0x2bc3aa(0x28c)](_0xbcd04d[_0x2bc3aa(0x409)],'fyWRz')){if(_0x18539a[_0x2bc3aa(0x20d)]===_0x16036f[_0x2bc3aa(0x1ed)])_0x5ec1d8=_0x16036f[_0x2bc3aa(0x255)];else{if(_0x16036f['hafFL'](_0x4e4de8[_0x2bc3aa(0x20d)],'incorrect'))_0x533473=_0x2bc3aa(0x3a2);else _0xca75e2=_0x16036f[_0x2bc3aa(0x3c7)];}}else _0x5baff5=_0x2bc3aa(0x368),_0x1b3e8b=_0xbcd04d[_0x2bc3aa(0x43c)];}}const _0x2405f1=document[_0x2bc3aa(0x2c1)](_0x2bc3aa(0x277));_0x2405f1[_0x2bc3aa(0x1cd)]=_0x2bc3aa(0x2a8)+_0x5baff5;let _0x238c3d=(_0x1175fa[_0x2bc3aa(0x3f8)]||[])['map']((_0x2c6978,_0x28bf8b)=>{const _0x22b68f=_0x2bc3aa,_0x5d938b={'guIUF':_0xbcd04d[_0x22b68f(0x1eb)]};if(_0xbcd04d[_0x22b68f(0x2be)](_0x22b68f(0x309),_0xbcd04d[_0x22b68f(0x3a7)])){const _0xac169d=_0x115480[_0x22b68f(0x206)](_0x2abc66[_0x22b68f(0x200)](_0x5d938b[_0x22b68f(0x1d0)]))||{};_0xac169d[_0x5b282c]&&(delete _0xac169d[_0x4f90f0],_0x27ee93['setItem']('userHistory',_0x4b6f6e[_0x22b68f(0x33c)](_0xac169d)),_0x8e0f50[_0x22b68f(0x218)](_0x22b68f(0x1c7)));}else{const _0x3d5ebf=_0xbcd04d['iVfnz'](_0x467b5d[_0x22b68f(0x280)],_0x28bf8b),_0xd367da=_0xbcd04d['iVfnz'](_0x2c6978['id'],_0x5b285e);let _0x403fe2=_0xbcd04d[_0x22b68f(0x342)];if(_0xd367da)_0x403fe2=_0xbcd04d[_0x22b68f(0x377)];else{if(_0x3d5ebf)_0x403fe2=_0xbcd04d[_0x22b68f(0x3df)];}return'<div\x20class=\x22p-3\x20rounded-lg\x20border\x20'+_0x403fe2+_0x22b68f(0x381)+String['fromCharCode'](_0xbcd04d[_0x22b68f(0x1f2)](0x41,_0x28bf8b))+_0x22b68f(0x1fa)+_0x2c6978['text']+_0x22b68f(0x22d);}})[_0x2bc3aa(0x35d)]('');const _0x1fbffa=_0x1175fa[_0x2bc3aa(0x344)]?_0x2bc3aa(0x41c)+_0x3403ef+_0x2bc3aa(0x26b)+_0x1175fa[_0x2bc3aa(0x344)]+'\x22\x20class=\x22w-full\x20rounded-lg\x22\x20controls></video></div>':'';let _0x337655='';if(_0x1175fa[_0x2bc3aa(0x378)])_0x337655+=_0x2bc3aa(0x22b)+_0x1175fa[_0x2bc3aa(0x378)]+_0x2bc3aa(0x3e6);if(_0x1175fa[_0x2bc3aa(0x3e8)])_0x337655+=_0x2bc3aa(0x450)+_0x1175fa['explanation_audio_hin']+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>';let _0xa9a20=(_0x1175fa['explanation_images']||[])[_0x2bc3aa(0x21a)](_0x50dcea=>_0x50dcea?_0x2bc3aa(0x399)+_0x50dcea+_0x2bc3aa(0x1ff):'')['join']('');_0x2405f1[_0x2bc3aa(0x376)]=_0x2bc3aa(0x24f)+(_0x3403ef+0x1)+'</h4>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<span\x20class=\x22text-sm\x20px-3\x20py-1\x20rounded-full\x20bg-'+(_0xbcd04d['hsAOX'](_0x5baff5,_0x2bc3aa(0x2ac))?_0x2bc3aa(0x2fb):_0xbcd04d[_0x2bc3aa(0x1b4)](_0x5baff5,_0xbcd04d[_0x2bc3aa(0x3eb)])?_0xbcd04d[_0x2bc3aa(0x1be)]:_0xbcd04d[_0x2bc3aa(0x225)])+_0x2bc3aa(0x43a)+_0x1b3e8b+_0x2bc3aa(0x259)+_0x1175fa[_0x2bc3aa(0x2f9)]+_0x2bc3aa(0x311)+_0x238c3d+_0x2bc3aa(0x36f)+(_0x1175fa[_0x2bc3aa(0x30a)]||_0xbcd04d[_0x2bc3aa(0x214)])+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20'+_0x1fbffa+_0x2bc3aa(0x3c5)+_0x337655+_0x2bc3aa(0x3c5)+_0xa9a20+'\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>',_0x28b646['appendChild'](_0x2405f1);}),initializeReviewVideos();}function initializeReviewVideos(){const _0xce3f7b=_0x2af812,_0x2da435={'jQbPg':_0xce3f7b(0x3f3)};document[_0xce3f7b(0x424)](_0xce3f7b(0x1d8))['forEach'](_0x138115=>{const _0x523677=_0xce3f7b,_0x270e78=_0x138115['dataset'][_0x523677(0x1b1)];if(_0x270e78&&_0x270e78[_0x523677(0x388)](_0x2da435[_0x523677(0x37c)]))setupVideo(_0x138115,_0x270e78);else _0x270e78&&(_0x138115[_0x523677(0x1b1)]=_0x270e78);});}function retakeQuiz(){const _0x1a5d46=_0x2af812,_0x1fc35c={'jpPdI':_0x1a5d46(0x297),'sXSeI':function(_0x4cbe51,_0x421046){return _0x4cbe51(_0x421046);},'jMxDu':_0x1a5d46(0x22e),'rHIfe':function(_0x5e00f9,_0x5c58c2){return _0x5e00f9!==_0x5c58c2;},'NdFUQ':'xgIzi','WRtXW':'AVGxY','kvJsW':_0x1a5d46(0x413),'wasvE':function(_0x11f30b){return _0x11f30b();}};_0x1fc35c[_0x1a5d46(0x251)](confirm,_0x1fc35c[_0x1a5d46(0x1b3)])&&(_0x1fc35c[_0x1a5d46(0x335)](_0x1fc35c[_0x1a5d46(0x408)],_0x1fc35c['WRtXW'])?(window[_0x1a5d46(0x266)][_0x1a5d46(0x2ec)][_0x1a5d46(0x284)](_0x1a5d46(0x1f9))&&localStorage['removeItem'](_0x1fc35c[_0x1a5d46(0x3f9)]),_0x1fc35c[_0x1a5d46(0x2b9)](clearProgress),location[_0x1a5d46(0x1bb)]()):_0x3544f3=_0x1fc35c[_0x1a5d46(0x32c)]);}function loadBookmarkedQuestions(){const _0x67f4af=_0x2af812,_0x7b810c={'ACAds':function(_0x284f03,_0x90836b){return _0x284f03<_0x90836b;},'MYcsz':_0x67f4af(0x427)},_0x26c61c=JSON[_0x67f4af(0x206)](localStorage[_0x67f4af(0x200)](_0x7b810c['MYcsz']))||[];_0x26c61c[_0x67f4af(0x2f3)](_0x3476b5=>{const _0x111f83=_0x67f4af;_0x3476b5[_0x111f83(0x2d7)]['includes'](quizName[_0x111f83(0x1b6)]()[_0x111f83(0x2af)](/ /g,'-'))&&(_0x7b810c[_0x111f83(0x3ab)](_0x3476b5[_0x111f83(0x298)],questionsData['length'])&&(questionStates[_0x3476b5['questionIndex']][_0x111f83(0x432)]=!![]));});}function toggleBookmark(){const _0x5ddc79=_0x2af812,_0x5ee73e={'SUItb':_0x5ddc79(0x427),'MtxzD':function(_0x1f285f,_0x5087de){return _0x1f285f!==_0x5087de;},'EmcSw':'hleSC','RloRf':function(_0x1f5da1){return _0x1f5da1();}},_0x4c4f56=!questionStates[currentQuestionIndex][_0x5ddc79(0x432)];questionStates[currentQuestionIndex][_0x5ddc79(0x432)]=_0x4c4f56;let _0x404688=JSON[_0x5ddc79(0x206)](localStorage['getItem'](_0x5ee73e['SUItb']))||[];if(_0x4c4f56){if(_0x5ee73e[_0x5ddc79(0x2fe)](_0x5ee73e[_0x5ddc79(0x390)],_0x5ee73e[_0x5ddc79(0x390)])){const _0x564c75=_0x80603c[_0x5ddc79(0x3c4)](_0x5ed553,arguments);return _0xa55515=null,_0x564c75;}else{const _0x555edd={'quizName':quizName,'quizFile':window[_0x5ddc79(0x266)]['pathname']['split']('/')[_0x5ddc79(0x2ea)](),'questionIndex':currentQuestionIndex,'question':questionsData[currentQuestionIndex],'hierarchy':hierarchy,'timestamp':Date[_0x5ddc79(0x3ef)]()};_0x404688[_0x5ddc79(0x2d9)](_0x555edd);}}else _0x404688=_0x404688[_0x5ddc79(0x3da)](_0x287675=>!(_0x287675[_0x5ddc79(0x2d7)][_0x5ddc79(0x388)](quizName['toLowerCase']()[_0x5ddc79(0x2af)](/ /g,'-'))&&_0x287675[_0x5ddc79(0x298)]===currentQuestionIndex));localStorage[_0x5ddc79(0x2f7)](_0x5ee73e[_0x5ddc79(0x2e0)],JSON[_0x5ddc79(0x33c)](_0x404688)),updateBookmarkButton(),_0x5ee73e['RloRf'](updateQuestionNav);}function updateBookmarkButton(){const _0x5c7a72=_0x2af812,_0x5189a2={'QxarX':_0x5c7a72(0x39a),'XPbkh':_0x5c7a72(0x357),'fvGsh':_0x5c7a72(0x28b),'aykiW':_0x5c7a72(0x296),'aQWeh':_0x5c7a72(0x316)},_0x4b6672=document['getElementById'](_0x5189a2[_0x5c7a72(0x1e6)]),_0xc83f15=document[_0x5c7a72(0x212)](_0x5189a2[_0x5c7a72(0x2b6)]),_0x4dd9f1=questionStates[currentQuestionIndex][_0x5c7a72(0x432)];_0x4b6672['className']=_0x4dd9f1?_0x5189a2[_0x5c7a72(0x250)]:_0x5189a2[_0x5c7a72(0x42d)],_0xc83f15[_0x5c7a72(0x41e)]=_0x4dd9f1?_0x5189a2[_0x5c7a72(0x1de)]:_0x5c7a72(0x428);}function toggleMarkForReview(){const _0x1094a4=_0x2af812,_0x27952f={'DsPzu':function(_0x4f9d42){return _0x4f9d42();}};questionStates[currentQuestionIndex][_0x1094a4(0x22a)]=!questionStates[currentQuestionIndex][_0x1094a4(0x22a)],_0x27952f[_0x1094a4(0x384)](updateMarkReviewButton),_0x27952f[_0x1094a4(0x384)](updateQuestionNav);}function updateMarkReviewButton(){const _0x5d6d24=_0x2af812,_0x4bfa0b={'trtfK':_0x5d6d24(0x308),'GVctV':_0x5d6d24(0x421),'gfNNR':_0x5d6d24(0x301),'PrpnF':_0x5d6d24(0x3ed)},_0x2fa5ad=document[_0x5d6d24(0x212)](_0x4bfa0b['trtfK']),_0x89cee4=document['getElementById'](_0x4bfa0b[_0x5d6d24(0x37e)]),_0x199b7d=questionStates[currentQuestionIndex][_0x5d6d24(0x22a)];_0x2fa5ad[_0x5d6d24(0x1cd)]=_0x199b7d?'gradient-purple\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center':_0x4bfa0b['gfNNR'],_0x89cee4[_0x5d6d24(0x41e)]=_0x199b7d?_0x4bfa0b[_0x5d6d24(0x3a0)]:'Mark\x20for\x20Review';}function previousQuestion(){const _0x57d60a=_0x2af812,_0x4e4f2b={'DYhiT':_0x57d60a(0x413),'Lrwtd':_0x57d60a(0x2a9),'QWHuY':_0x57d60a(0x346),'jCDLI':_0x57d60a(0x285),'DSsPH':'\x20>\x20','IiZph':function(_0xe4d3b8,_0x533eb6){return _0xe4d3b8>_0x533eb6;},'TMLlQ':_0x57d60a(0x20f),'bXCTz':_0x57d60a(0x3bf),'ePSUh':function(_0x228319,_0x321295){return _0x228319-_0x321295;},'RquIJ':function(_0x20d456){return _0x20d456();},'DkkTq':function(_0x402bd8){return _0x402bd8();}};if(_0x4e4f2b[_0x57d60a(0x42a)](currentQuestionIndex,0x0)){if(questionStartTime){if(_0x4e4f2b[_0x57d60a(0x324)]===_0x4e4f2b[_0x57d60a(0x23f)]){const _0x1cb6fb=_0x2d97e4[_0x57d60a(0x206)](_0xbb0183[_0x57d60a(0x200)](_0x4e4f2b[_0x57d60a(0x209)]));if(_0x1cb6fb){const _0x23b745=_0x4e4f2b[_0x57d60a(0x39f)][_0x57d60a(0x1f8)]('|');let _0x7e3f08=0x0;while(!![]){switch(_0x23b745[_0x7e3f08++]){case'0':_0x595808=_0x1cb6fb[_0x57d60a(0x1df)];continue;case'1':_0x18d548[_0x57d60a(0x278)]=_0x150942+_0x4e4f2b['QWHuY'];continue;case'2':_0xe4825f=_0x1cb6fb[_0x57d60a(0x448)];continue;case'3':_0x5498bc['getElementById'](_0x57d60a(0x226))[_0x57d60a(0x41e)]=_0x34c435[_0x57d60a(0x3a9)];continue;case'4':_0x2f0a94[_0x57d60a(0x212)](_0x4e4f2b['jCDLI'])[_0x57d60a(0x41e)]=_0x14af73[_0x57d60a(0x35d)](_0x4e4f2b['DSsPH']);continue;case'5':_0x329dfa=_0x1cb6fb[_0x57d60a(0x2ae)];continue;}break;}}}else questionStates[currentQuestionIndex][_0x57d60a(0x350)]+=_0x4e4f2b[_0x57d60a(0x36a)](Date[_0x57d60a(0x3ef)](),questionStartTime);}currentQuestionIndex--,_0x4e4f2b[_0x57d60a(0x425)](displayQuestion),_0x4e4f2b[_0x57d60a(0x29d)](saveProgress);}}function nextQuestion(){const _0x4931df=_0x2af812,_0x4758fa={'lZIAc':function(_0x503684,_0x5d958a){return _0x503684===_0x5d958a;},'UYpnD':function(_0x4ecf3b,_0xb9c2af){return _0x4ecf3b-_0xb9c2af;},'MTWml':function(_0x273bb3,_0x831a15){return _0x273bb3(_0x831a15);},'XtmRT':_0x4931df(0x289),'BVzeB':function(_0x1f0c52,_0x1f5472){return _0x1f0c52<_0x1f5472;},'bbaWP':function(_0x4811f0){return _0x4811f0();},'inPfb':function(_0x513018,_0x402a26){return _0x513018!==_0x402a26;},'ibCBN':'TSLhN','scQfq':_0x4931df(0x39d),'yDKiS':_0x4931df(0x2df),'mipvp':function(_0x4216fd){return _0x4216fd();},'LJkmU':function(_0x21c17a,_0x3290cd){return _0x21c17a!==_0x3290cd;},'wMQAe':_0x4931df(0x32b),'TGHPb':function(_0x5efa5d,_0x3c80df){return _0x5efa5d(_0x3c80df);},'gTIae':_0x4931df(0x293)};questionStartTime&&(_0x4758fa[_0x4931df(0x1cf)](_0x4931df(0x3ee),_0x4758fa['ibCBN'])?_0x1686ff[_0x4931df(0x401)][_0x4931df(0x313)](_0x4931df(0x36d),_0x4758fa[_0x4931df(0x310)](_0x303f85,_0x5e7856)):questionStates[currentQuestionIndex][_0x4931df(0x350)]+=Date[_0x4931df(0x3ef)]()-questionStartTime);if(_0x4758fa[_0x4931df(0x244)](currentQuestionIndex,_0x4758fa['UYpnD'](questionsData[_0x4931df(0x3a9)],0x1)))currentQuestionIndex++,displayQuestion(),_0x4758fa[_0x4931df(0x2b7)](saveProgress);else{if(_0x4758fa[_0x4931df(0x310)](_0x4931df(0x39d),_0x4758fa[_0x4931df(0x449)])){if(currentMode==='test'||currentMode===_0x4758fa['yDKiS'])confirm('You\x20have\x20reached\x20the\x20end\x20of\x20the\x20quiz.\x20Would\x20you\x20like\x20to\x20submit\x20your\x20answers\x20now?')&&_0x4758fa['mipvp'](submitQuiz);else{if(_0x4758fa[_0x4931df(0x2c4)](_0x4758fa['wMQAe'],_0x4758fa[_0x4931df(0x39c)])){const _0x1d5d9d=_0x4758fa[_0x4931df(0x446)](_0x4758fa[_0x4931df(0x36e)](_0x3bc31f,_0x3f3ea0[_0x4931df(0x396)]),0x1),_0x3b5ab1=_0x3f0816[_0x4931df(0x424)](_0x4758fa[_0x4931df(0x27f)]);if(_0x4758fa['BVzeB'](_0x1d5d9d,_0x3b5ab1[_0x4931df(0x3a9)]))_0x1e5111(_0x1d5d9d);}else _0x4758fa[_0x4931df(0x2ba)](confirm,_0x4758fa[_0x4931df(0x1e9)])&&(currentQuestionIndex=0x0,displayQuestion(),_0x4758fa[_0x4931df(0x370)](saveProgress));}}else _0x3664fe[_0x4931df(0x353)](),_0x4758fa[_0x4931df(0x2b7)](_0x445b88);}}function startTimer(){const _0x5447cf=_0x2af812,_0x49fa71={'miaZd':'modeModal','QKzqg':function(_0x5a074f){return _0x5a074f();},'TXdzb':'userHistory','DaGxR':_0x5447cf(0x2eb),'PyxVi':function(_0x18f2e4){return _0x18f2e4();},'iVSix':function(_0x475e6f,_0x423609){return _0x475e6f<=_0x423609;},'KEvXq':function(_0x1eab10,_0x26fcf6){return _0x1eab10!==_0x26fcf6;},'JWjkp':'NXAcm','DiOjL':_0x5447cf(0x33a),'QnBDC':function(_0x123f77,_0x494933){return _0x123f77(_0x494933);},'RdzTU':function(_0x54da84,_0x1f3bcf){return _0x54da84===_0x1f3bcf;},'PdlRJ':_0x5447cf(0x2df),'RGwDZ':_0x5447cf(0x2de),'WxqzX':function(_0x391e6d){return _0x391e6d();},'bXWCV':function(_0xfd1151,_0x5a8f62){return _0xfd1151===_0x5a8f62;},'ZxVFl':_0x5447cf(0x41a),'AZisR':function(_0x42be71){return _0x42be71();},'nRLCq':function(_0x318ae2){return _0x318ae2();},'tXZDS':function(_0x512d44,_0x7a28db,_0x4a61a6){return _0x512d44(_0x7a28db,_0x4a61a6);}};if(timer)_0x49fa71[_0x5447cf(0x282)](clearInterval,timer);timeRemaining=0x78,_0x49fa71[_0x5447cf(0x404)](updateTimerDisplay),timer=_0x49fa71['tXZDS'](setInterval,()=>{const _0x1ab3df=_0x5447cf;timeRemaining--,_0x49fa71[_0x1ab3df(0x351)](updateTimerDisplay);if(_0x49fa71[_0x1ab3df(0x325)](timeRemaining,0x0)){if(_0x49fa71[_0x1ab3df(0x3be)](_0x49fa71['JWjkp'],_0x49fa71[_0x1ab3df(0x44a)]))_0x49fa71[_0x1ab3df(0x282)](clearInterval,timer),_0x49fa71[_0x1ab3df(0x2dd)](currentMode,_0x49fa71[_0x1ab3df(0x40b)])?_0x49fa71['RdzTU'](_0x49fa71['RGwDZ'],_0x49fa71[_0x1ab3df(0x347)])?_0x49fa71[_0x1ab3df(0x21d)](submitQuiz):(_0x184e36[_0x1ab3df(0x212)](_0x49fa71[_0x1ab3df(0x30e)])[_0x1ab3df(0x253)][_0x1ab3df(0x261)]='none',_0x49fa71[_0x1ab3df(0x30c)](_0x13cc38)):_0x49fa71['bXWCV'](_0x49fa71[_0x1ab3df(0x23b)],_0x49fa71[_0x1ab3df(0x23b)])?_0x49fa71[_0x1ab3df(0x2a3)](nextQuestion):_0xb07de3(_0xa16c64,_0x14a29f);else{const _0x5bdc29=_0x3f6ce8[_0x1ab3df(0x206)](_0x2f2e9e['getItem'](_0x49fa71[_0x1ab3df(0x37b)]))||{},_0x58fe74=_0x5f3f62[_0x1ab3df(0x3a9)],_0x2121db=_0x24eb7b[_0x1ab3df(0x208)]||0x0;_0x5bdc29[_0x2b0afe]={'score':_0x2121db,'total':_0x58fe74,'status':_0x49fa71[_0x1ab3df(0x361)],'completedOn':new _0x346726()[_0x1ab3df(0x248)]()},_0x1c9cde[_0x1ab3df(0x2f7)](_0x49fa71['TXdzb'],_0x2aeb05[_0x1ab3df(0x33c)](_0x5bdc29));}}},0x3e8);}function updateTimerDisplay(){const _0x5f0ae6=_0x2af812,_0x19a2d2={'Iaasl':function(_0x619156,_0xb8003){return _0x619156/_0xb8003;},'koFbg':function(_0x4f727e,_0xf8ffbc){return _0x4f727e%_0xf8ffbc;},'oDnnB':'timeDisplay','zWSVR':function(_0x42eb02,_0x34360a){return _0x42eb02+_0x34360a;}},_0x13f00a=Math[_0x5f0ae6(0x3fd)](_0x19a2d2['Iaasl'](timeRemaining,0x3c)),_0x356a32=_0x19a2d2['koFbg'](timeRemaining,0x3c);document[_0x5f0ae6(0x212)](_0x19a2d2[_0x5f0ae6(0x220)])[_0x5f0ae6(0x41e)]=_0x19a2d2['zWSVR'](_0x19a2d2[_0x5f0ae6(0x258)](_0x13f00a,':'),_0x356a32[_0x5f0ae6(0x40e)]()['padStart'](0x2,'0'));}function toggleSidebar(){const _0x5e3074=_0x2af812,_0xb57644={'CrhQf':_0x5e3074(0x34a)};document[_0x5e3074(0x212)](_0x5e3074(0x270))['classList'][_0x5e3074(0x313)](_0xb57644['CrhQf']);}document['addEventListener']('DOMContentLoaded',()=>{const _0x2b571b=_0x2af812,_0x4d1add={'COqcF':function(_0x31dfe2){return _0x31dfe2();},'rFUJA':_0x2b571b(0x416),'UXOoo':_0x2b571b(0x30b),'KfoAi':function(_0x3768fd,_0x57817b){return _0x3768fd-_0x57817b;},'SGjNA':function(_0x2e5941,_0x2ee325){return _0x2e5941===_0x2ee325;},'hfpHz':_0x2b571b(0x235),'CeItr':function(_0x3823c6){return _0x3823c6();},'jefqY':_0x2b571b(0x32a),'rVwml':'IuVAy','KKuii':function(_0x64657){return _0x64657();},'ODrhc':_0x2b571b(0x21b),'qJGXE':function(_0x498b7b,_0x8128e3){return _0x498b7b!==_0x8128e3;},'vbXPC':'QPVtQ','EdMOi':_0x2b571b(0x1d2),'Wzgrn':function(_0x428373){return _0x428373();},'gmCNs':function(_0x56f070){return _0x56f070();}};if(resume)_0x4d1add[_0x2b571b(0x24b)](_0x4d1add[_0x2b571b(0x443)],_0x4d1add[_0x2b571b(0x443)])?_0x4d1add[_0x2b571b(0x3ae)](loadProgress)?_0x4d1add[_0x2b571b(0x24b)](_0x4d1add[_0x2b571b(0x205)],_0x4d1add[_0x2b571b(0x391)])?_0x4d1add[_0x2b571b(0x451)](_0x2eb906):(document[_0x2b571b(0x212)](_0x4d1add[_0x2b571b(0x28d)])[_0x2b571b(0x253)][_0x2b571b(0x261)]=_0x4d1add[_0x2b571b(0x222)],_0x4d1add[_0x2b571b(0x3ae)](initializeQuiz)):(_0x4d1add[_0x2b571b(0x2fd)](clearProgress),document[_0x2b571b(0x212)](_0x4d1add[_0x2b571b(0x28d)])[_0x2b571b(0x253)][_0x2b571b(0x261)]=_0x4d1add[_0x2b571b(0x32f)]):(_0x177a56=_0x222e57,_0x58cfff[_0x2b571b(0x212)](_0x4d1add[_0x2b571b(0x28d)])[_0x2b571b(0x253)][_0x2b571b(0x261)]=_0x4d1add[_0x2b571b(0x222)],_0x4d1add[_0x2b571b(0x451)](_0x1d424b));else!window[_0x2b571b(0x266)][_0x2b571b(0x2ec)][_0x2b571b(0x284)](_0x2b571b(0x1f9))?_0x4d1add['qJGXE'](_0x4d1add[_0x2b571b(0x1ba)],_0x4d1add['EdMOi'])?(_0x4d1add[_0x2b571b(0x1e8)](clearProgress),document[_0x2b571b(0x212)](_0x4d1add[_0x2b571b(0x28d)])[_0x2b571b(0x253)]['display']=_0x4d1add[_0x2b571b(0x32f)]):(_0x40bb34&&(_0x1cce64[_0x540036][_0x2b571b(0x350)]+=_0x4d1add[_0x2b571b(0x303)](_0x81db5d[_0x2b571b(0x3ef)](),_0x308e18)),_0x42b883--,_0x4d1add[_0x2b571b(0x451)](_0x5ce5c4),_0x49b1f1()):_0x4d1add[_0x2b571b(0x331)](initializeQuiz);}),document[_0x2af812(0x1bd)](_0x2af812(0x283),function(_0x280e54){const _0x59aa7f=_0x2af812,_0x54368a={'pWaaO':function(_0x5dfd1e,_0x363620){return _0x5dfd1e!==_0x363620;},'BEWQc':_0x59aa7f(0x416),'haECY':_0x59aa7f(0x30b),'blCzw':_0x59aa7f(0x3fb),'dpAeC':function(_0x131f33,_0x2d4185){return _0x131f33>=_0x2d4185;},'NnNXy':_0x59aa7f(0x267),'cJvFZ':function(_0x3653df,_0x560012){return _0x3653df-_0x560012;},'VeVeJ':function(_0x100750,_0xd67ad0){return _0x100750(_0xd67ad0);},'psSYa':_0x59aa7f(0x289),'CbhKX':function(_0x32ec05,_0xdd1d6e){return _0x32ec05<_0xdd1d6e;},'qDLBM':function(_0x4572ca,_0xa4e79f){return _0x4572ca===_0xa4e79f;},'KQNxH':_0x59aa7f(0x2d2),'fNZto':function(_0x196f84){return _0x196f84();},'quXjt':function(_0x4cc217,_0x33d354){return _0x4cc217===_0x33d354;},'QwhVs':'ArrowRight','SIlPm':function(_0x3d8a59,_0x2764eb){return _0x3d8a59===_0x2764eb;},'QnbMA':function(_0x335d5d,_0x46284d){return _0x335d5d===_0x46284d;},'aAIDL':'study','HZgIt':_0x59aa7f(0x3d5),'eMjrB':function(_0x286bc2,_0x49254e){return _0x286bc2===_0x49254e;},'npmwr':function(_0x74cd54,_0x1650d8){return _0x74cd54===_0x1650d8;},'DQAos':_0x59aa7f(0x29e),'slGNa':_0x59aa7f(0x2df),'YkKeH':function(_0x1a098e,_0x210451){return _0x1a098e===_0x210451;},'devLf':_0x59aa7f(0x2ed),'FJwkE':function(_0x9e6364){return _0x9e6364();}};if(_0x54368a[_0x59aa7f(0x1d6)](document['getElementById'](_0x54368a['BEWQc'])[_0x59aa7f(0x253)]['display'],_0x54368a['haECY']))return;if(document[_0x59aa7f(0x212)](_0x59aa7f(0x445))['classList'][_0x59aa7f(0x21f)](_0x54368a[_0x59aa7f(0x34b)])===![])return;if(_0x54368a['dpAeC'](_0x280e54[_0x59aa7f(0x396)],'1')&&_0x280e54[_0x59aa7f(0x396)]<='4'){if(_0x54368a['pWaaO'](_0x59aa7f(0x267),_0x54368a[_0x59aa7f(0x345)]))_0x3c3ff6[_0x59aa7f(0x401)][_0x59aa7f(0x3af)](_0x59aa7f(0x3fb));else{const _0x5558df=_0x54368a[_0x59aa7f(0x21c)](_0x54368a['VeVeJ'](parseInt,_0x280e54['key']),0x1),_0x2b754a=document[_0x59aa7f(0x424)](_0x54368a[_0x59aa7f(0x328)]);if(_0x54368a[_0x59aa7f(0x202)](_0x5558df,_0x2b754a[_0x59aa7f(0x3a9)]))_0x54368a['VeVeJ'](selectOption,_0x5558df);}}else{if(_0x54368a[_0x59aa7f(0x429)](_0x280e54['key'],_0x54368a[_0x59aa7f(0x2ab)]))_0x54368a['fNZto'](previousQuestion);else{if(_0x54368a[_0x59aa7f(0x397)](_0x280e54[_0x59aa7f(0x396)],_0x54368a[_0x59aa7f(0x34d)])||_0x280e54['key']==='\x20')_0x280e54[_0x59aa7f(0x353)](),nextQuestion();else{if(_0x54368a[_0x59aa7f(0x27b)](_0x280e54[_0x59aa7f(0x396)]['toLowerCase'](),'b')&&(_0x54368a[_0x59aa7f(0x32d)](currentMode,_0x54368a[_0x59aa7f(0x3c2)])||currentMode===_0x54368a['HZgIt']))_0x54368a['fNZto'](toggleBookmark);else{if(_0x54368a[_0x59aa7f(0x1c4)](_0x280e54['key'][_0x59aa7f(0x1b6)](),'m')&&(_0x54368a[_0x59aa7f(0x3e4)](currentMode,_0x54368a[_0x59aa7f(0x333)])||_0x54368a[_0x59aa7f(0x1c4)](currentMode,_0x54368a[_0x59aa7f(0x430)])))_0x54368a[_0x59aa7f(0x1ec)](_0x54368a['devLf'],_0x54368a[_0x59aa7f(0x242)])?toggleMarkForReview():_0x17c5b8=_0x59aa7f(0x35f);else _0x54368a[_0x59aa7f(0x32d)](_0x280e54[_0x59aa7f(0x396)]['toLowerCase'](),'s')&&(currentMode===_0x54368a['DQAos']||_0x54368a[_0x59aa7f(0x3e4)](currentMode,_0x54368a[_0x59aa7f(0x430)]))&&_0x54368a['FJwkE'](submitQuiz);}}}}});</script>

</body></html>